<SEC-DOCUMENT>0001140361-23-008161.txt : 20230223
<SEC-HEADER>0001140361-23-008161.hdr.sgml : 20230223
<ACCEPTANCE-DATETIME>20230223070257
ACCESSION NUMBER:		0001140361-23-008161
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20230223
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230223
DATE AS OF CHANGE:		20230223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coeur Mining, Inc.
		CENTRAL INDEX KEY:			0000215466
		STANDARD INDUSTRIAL CLASSIFICATION:	GOLD & SILVER ORES [1040]
		IRS NUMBER:				820109423
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08641
		FILM NUMBER:		23655878

	BUSINESS ADDRESS:	
		STREET 1:		200 SOUTH WACKER DRIVE
		STREET 2:		SUITE 2100
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-489-5800

	MAIL ADDRESS:	
		STREET 1:		200 SOUTH WACKER DRIVE
		STREET 2:		SUITE 2100
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COEUR D ALENE MINES CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10048619_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:cde="http://coeur.com/20230223" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_487868727f434ef59ce67b8e0fc20c91" contextRef="c20230223to20230223" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_b78026c98294479babbbf526fa4fb3f3" contextRef="c20230223to20230223">0000215466</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cde-20230223.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230223to20230223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000215466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-23</xbrli:startDate><xbrli:endDate>2023-02-23</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549<br />
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">
        <hr style="height: 2px; width: 15%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
<div>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_469625cad05f4f449d7a4a613cb6f0b4" contextRef="c20230223to20230223">8-K</ix:nonNumeric></div>
</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT PURSUANT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TO SECTION 13 OR 15 (d) OF THE</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES EXCHANGE ACT OF 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_09c6b6c393fd4630803b3ab8d2ed30cf" contextRef="c20230223to20230223" format="ixt:date-monthname-day-year-en">February 23, 2023</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_fe17b5a287aa4d15a203553ca67aef5b" contextRef="c20230223to20230223">Coeur Mining, Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_6e080d9efc2f451eb9a16d4a9a19c719" contextRef="c20230223to20230223" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_01eeabce43754e6faffd908ca0f2e086" contextRef="c20230223to20230223">1-8641</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_ea2579092e004ad5b7923e8622a1ada0" contextRef="c20230223to20230223">82-0109423</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
            </td>

    <td style="width: 33.3%; vertical-align: top;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_9d69921b73b04a06ade81db606ff8d84" contextRef="c20230223to20230223">200 S. Wacker Dr.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_a9b84552928648cfbc48785c2cf7a927" contextRef="c20230223to20230223">Suite 2100</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_96fcb7e5c9634fafa1d9ef1f5e66b1d1" contextRef="c20230223to20230223">Chicago</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_468760e1e5124395bfa2592e2ff571c6" contextRef="c20230223to20230223">IL</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_2e07e99441d3457e854116a958f462be" contextRef="c20230223to20230223">60606</ix:nonNumeric><br />
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Address of principal executive offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant&#8217;s telephone number, including area code:&#160; (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_8cab33a2567f40b2bdfec9c6c3eb458d" contextRef="c20230223to20230223">312</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_0f5e0f60cc05474db2431ee854b6dc9b" contextRef="c20230223to20230223">489-5800</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_5d039c480f6d42159a2463ca3e4a8600" contextRef="c20230223to20230223" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_2640b58eedb34fe6bab45164cce13bd0" contextRef="c20230223to20230223" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_9e02159e0ee341c188b03a57680cd9a1" contextRef="c20230223to20230223" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_2620bb9c7fa340a589e814833c78f9ce" contextRef="c20230223to20230223" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Title of each class</div>
            </td>

    <td style="width: 34%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Trading Symbol(s)</div>
            </td>

    <td style="width: 33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_bf8c08b66cdc442ca20ee532962b450c" contextRef="c20230223to20230223">Common Stock (par value $.01 per share)</ix:nonNumeric><br />
            </td>

    <td style="width: 34%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_39ca8723c7b94777bf9d7621b11e41ce" contextRef="c20230223to20230223">CDE</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7ab7ac66a41548e487d4a3ac3d3e9157" contextRef="c20230223to20230223" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric><br />
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2
        of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="text-align: right; text-indent: 36pt; margin-left: 288pt; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_a2f1f6cc2fa24147bbda075d3f44d7cb" contextRef="c20230223to20230223" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.<span style="color: rgb(0, 0, 0);">&#160; &#160;&#160; </span>&#9744;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
<div><br /></div>

        <div>
          <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify; text-indent: 36pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Each of the ATM Equity Offering Sales Agreement, dated as of February 23, 2023, among Coeur Mining, Inc. and BMO Capital Markets
        Corp. and RBC Capital Markets, LLC, which is filed as Exhibit 1.1 of this Current Report on Form 8-K, and the opinion of Gibson, Dunn &amp; Crutcher LLP, which is filed as Exhibit 5.1 to this Current Report on Form 8-K, is incorporated herein by
        reference. The opinion was issued in connection with the filing of the prospectus supplement on Form 424(b)(5), filed with the U.S. Securities and Exchange Commission on equal date herewith, forming part of the registration statement (File No.
        333-262799).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 72pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">List of Exhibits</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold;">Exhibit No.</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 89%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><a href="brhc10048619_ex1-1.htm">1.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">ATM Equity Offering Sales Agreement, dated as of February 23, 2023, among Coeur Mining, Inc. and BMO Capital Markets Corp. and RBC Capital Markets, LLC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><a href="brhc10048619_ex5-1.htm">5.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Opinion of Gibson, Dunn &amp; Crutcher LLP.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);"><a href="brhc10048619_ex5-1.htm">23.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Consent of Gibson, Dunn &amp; Crutcher LLP (included in its opinion filed as Exhibit 5.1).</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">104</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 89%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">&#160;SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 46.58%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 53.42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; text-indent: -9pt; margin-left: 9pt; color: rgb(0, 0, 0);">COEUR MINING, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 46.58%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 53.42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 46.58%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 53.42%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">By: /s/ Thomas S. Whelan</div>
            </td>

  </tr>

  <tr>

    <td style="width: 46.58%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 53.42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Name: Thomas S. Whelan</div>
            </td>

  </tr>

  <tr>

    <td style="width: 46.58%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 53.42%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Title: Senior Vice President and Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </span></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">DATED:&#160; February 23, 2023</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>brhc10048619_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right; font-size: 10pt;"><font style="font-weight: bold;">Exhibit 1.1<br>
      </font></div>
    <div style="text-align: right; font-size: 10pt;"><font style="font-weight: bold;"><br>
      </font></div>
    <div style="text-align: center;">
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">COEUR MINING, INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">$100,000,000 Shares of</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Common Stock</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">($0.01 Par Value Per Share)</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ATM EQUITY OFFERING</font><font style="font-size: 10pt;"><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup>&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">SALES AGREEMENT</font></font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">February 23, 2023</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BMO Capital Markets Corp.</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">151 W 42nd Street</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, NY 10036</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RBC Capital Markets, LLC</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">200 Vesey Street, 8th Floor</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Brookfield Place New York</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10281</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">Coeur Mining, Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>&#8221;), confirms its
        agreement (this &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agreement</font>&#8221;) with BMO Capital Markets Corp. (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">BMO</font>&#8221;) and RBC Capital Markets, LLC (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">RBC</font>&#8221;, and together with BMO, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agents</font>&#8221; and each individually, an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agent</font>&#8221;) with respect to the issuance and sale from time to time by the Company of shares (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Shares</font>&#8221;) of the Company&#8217;s common stock,
        $0.01 par value per share (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Common Stock</font>&#8221;), having an aggregate offering price of up to <font style="font-family: 'Times New Roman'; font-weight: bold;">One</font>&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">Hundred Million United States Dollars ($100,000,000)</font> (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Maximum Amount</font>&#8221;) through or to the Agents, as
        sales agents or principals, on the terms and subject to the conditions set forth in this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Commission</font>&#8221;)





        an &#8220;automatic shelf registration statement,&#8221; as defined under Rule 405 (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Rule 405</font>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Act</font>&#8221;), on Form S-3 (Registration No. 333-262799) covering the public offering and sale of certain securities of the Company, including the Shares (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">registration statement</font>&#8221;), under the Act and the rules and regulations of the Commission thereunder (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Rules and Regulations</font>&#8221;).&#160; The
        Registration Statement (as defined below) sets forth the material terms of the offering, sale and plan of distribution of the Shares and contains additional information concerning the Company and its business.&#160; Except where the context otherwise
        requires, the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Registration Statement</font>&#8221; means the registration statement, as amended by any post-effective amendments thereto at the time of the registration statement&#8217;s
        effectiveness for purposes of Section 11 of the Act, as such section applies to each Agent, as well as any new registration statement or post-effective amendment as may have been filed pursuant to Section 3(h) or (i) of this Agreement, including
        (i) the exhibits and any schedules thereto and all documents filed as a part thereof or incorporated, or deemed to be incorporated, by reference therein pursuant to Item 12 of Form S-3 under the Act at such time and (ii) any information or
        documents contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations, to the extent such information is deemed, pursuant to Rule 430B or Rule 430C of the Rules and
        Regulations, to be part of the registration statement at the effective time.&#160; Except where the context requires, the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Base Prospectus</font>&#8221; means the prospectus filed as part
        of the Registration Statement, as amended in the form in which it has been filed most recently with the Commission, including the documents incorporated or deemed incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act.&#160;
        Except where the context otherwise requires, the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Prospectus Supplement</font>&#8221; means the most recent prospectus supplement relating to the Shares, to be prepared and filed by
        the Company with the Commission pursuant to Rule 424(b) of the Rules and Regulations on or before the second business day after the date hereof (or such earlier time as may be required under the Act or agreed to by the Company and each Agent), in
        the form furnished by the Company to the Agents in connection with the offering of the Shares, including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act.&#160; Except where the
        context otherwise requires, the term &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Prospectus</font>&#8221; means the Prospectus Supplement (and any additional prospectus supplement prepared in accordance with the last sentence of
        Section 3(cc) and filed in accordance with the provisions of Rule 424(b) of the Rules and Regulations), together with the Base Prospectus attached to or used with the Prospectus Supplement.&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Permitted Free Writing Prospectus</font>&#8221; has the meaning set forth in Section 3(g).&#160; Any reference herein to the Registration Statement, the Base Prospectus, the Prospectus Supplement, the Prospectus and any Permitted Free
        Writing Prospectus shall, unless otherwise stated, be deemed to refer to and include the documents, if any, incorporated, or deemed to be incorporated, by reference therein (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Incorporated





          Documents</font>&#8221;), including, unless the context otherwise requires, the documents, if any, filed as exhibits to such Incorporated Documents.&#160; Any reference herein to the terms &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">amend</font>,&#8221;





        &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">amendment</font>&#8221; or &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">supplement</font>&#8221; with respect to the Registration Statement, the Base Prospectus, the
        Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus shall, unless stated otherwise, be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and
        regulations of the Commission thereunder (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exchange Act</font>&#8221;) on or after the initial effective date of the Registration Statement or the date of the Base
        Prospectus, the Prospectus Supplement, the Prospectus or such Permitted Free Writing Prospectus, as the case may be, and deemed to be incorporated therein by reference. For purposes of this Agreement, all references to the Registration Statement,
        the Base Prospectus, the Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus or any amendment or supplement thereto shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering,
        Analysis and Retrieval system (or any successor system) (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">EDGAR</font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company confirms its agreement with each Agent as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Sale and Delivery of the Shares.</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Agency Transactions.</font>&#160; On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company and each of the Agents agree that
            the&#160; Company may issue and sell the Shares through an Agent, as sales agent for the Company for the purpose of soliciting purchases of the Shares from the Company pursuant to this Agreement (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agency Transaction</font>&#8221;) as follows:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company may, from time to time,
            propose to an Agent determined in the sole discretion of the Company (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Designated Agent</font>&#8221;) the terms of an Agency Transaction by means of a written notice or by a
            telephone call (confirmed promptly by electronic mail in a form substantially similar to <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit A</u></font> hereto (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agency Transaction Notice</font>&#8221;)) from any of the individuals listed as authorized representatives of the Company on <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Schedule 1</u></font> hereto
            (each, an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Authorized Company Representative</font>&#8221;), such proposal to include: the trading day(s) for the New York Stock Exchange (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Exchange</font>&#8221;) (which may not be a day on which the Exchange is scheduled to close prior to its regular weekday closing time) on which the Shares are to be sold (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Trading Day</font>&#8221;); the maximum number of Shares that the Company wishes to sell in the aggregate and on each Trading Day (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Placement Shares</font>&#8221;);





            and the minimum price at which the Company is willing to sell the Shares (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Floor Price</font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If such proposed terms for an Agency
            Transaction are acceptable to the Designated Agent, it shall promptly confirm the terms by countersigning the Agency Transaction Notice for such Agency Transaction and emailing it to an Authorized Company Representative. The Agency Transaction
            Notice shall be effective unless and until (i) the Designated Agent, in accordance with the notice requirements set forth in Section 1(a)(iv) below, suspends or terminates the Agency Transaction Notice for any reason, in its sole discretion,
            (ii) the entire amount of the Placement Shares have been sold, (iii) in accordance with the notice requirements set forth in Section 1(a)(iv) below, the Company suspends or terminates the Agency Transaction Notice for any reason, in its sole
            discretion, (iv) the Company issues a subsequent Agency Transaction Notice with parameters superseding those on the earlier dated Agency Transaction Notice, or (v) this Agreement has been terminated under the provisions of Section 6.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Subject to the terms and conditions
            hereof, each Designated Agent shall use its commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to sell all of the Shares designated in, and subject to the terms of, such
            Agency Transaction Notice.&#160; No Designated Agent shall sell any Share at a price lower than the Floor Price.&#160; The Company acknowledges and agrees with each Designated Agent that (x) there can be no assurance that the Designated Agent will be
            successful in selling all or any of such Shares, (y) the Designated Agent shall incur no liability or obligation to the Company or any other person or entity if it does not sell any Shares for any reason and (z) the Designated Agent shall be
            under no obligation to purchase any Shares on a principal basis pursuant to this Agreement (except in the case of a Principal Transaction (as defined below) pursuant to this Agreement and the relevant Terms Agreement (as defined below)).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company, acting through an
            Authorized Company Representative, or the applicable Designated Agent under the Agency Transaction Notice may, upon notice to the other party hereto by writing or by telephone (confirmed promptly by electronic mail), suspend an offering of the
            Shares for any reason and at any time; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that such suspension shall not affect
            or impair the parties&#8217; respective obligations with respect to the Shares sold hereunder prior to the giving of such notice.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">If the terms of any Agency Transaction
            as set forth in an Agency Transaction Notice contemplate that the Shares shall be sold on more than one Trading Day, then the Company and the Designated Agent shall mutually agree to such additional terms and conditions as they deem necessary
            in respect of such multiple Trading Days, and such additional terms and conditions shall be binding to the same extent as any other terms contained in the relevant Agency Transaction Notice.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Each Agent, as a sales agent in an
            Agency Transaction, shall not make any sales of the Shares on behalf of the Company, pursuant to this Agreement, other than (x) by means of ordinary brokers&#8217; transactions that qualify for delivery of the Prospectus in accordance with Rule 153
            of the Rules and Regulations and meet the definition of an &#8220;at the market offering&#8221; under Rule 415(a)(4) of the Rules and Regulations and (y) such other sales of the Shares on behalf of the Company in its capacity as agent of the Company as
            shall be agreed by the Company and the Agent in writing.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The compensation to a Designated Agent
            for sales of the Shares in an Agency Transaction with respect to which such Designated Agent acts as sales agent hereunder shall be up to 1.5% of the gross sales price per Share sold through such Designated Agent.&#160; The Designated Agent shall
            provide written confirmation to the Company (which may be provided by email to an Authorized Company Representative) following the close of trading on the Exchange on each Trading Day on which Shares are sold in an Agency Transaction under this
            Agreement, setting forth (i) the number of Shares sold on such Trading Day, (ii) the gross offering proceeds received from such sales, (iii) the commission payable by the Company to the Designated Agent with respect to such sales and (iv) the
            net offering proceeds (being the gross offering proceeds for such sales less the commission payable for such sales and less any transaction fees, transfer taxes or similar taxes or fees imposed by any governmental entity or self-regulatory
            organization in respect of such sales) (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Net Offering Proceeds</font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Settlement for sales of the Shares in
            an Agency Transaction pursuant to this Agreement shall occur on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each such day, an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Agency Settlement Date</font>&#8221;).&#160; On each Agency Settlement Date, the Shares sold through the Designated Agent in Agency Transactions for settlement on such date shall be issued and
            delivered by the Company to such Designated Agent against payment by such Designated Agent to the Company of the Net Offering Proceeds from the sale of such Shares.&#160; Settlement for all such Shares shall be effected by free delivery of the
            Shares by the Company or its transfer agent to the Designated Agent&#8217;s or its designee&#8217;s account (<font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that the Designated Agent shall have given the Company written
            notice of such designee prior to the relevant Agency Settlement Date) at The Depository Trust Company or by such other means of delivery as may be mutually agreed upon by the parties hereto, which in all cases shall be freely tradable,
            transferable, registered shares in good deliverable form, in return for payment in same-day funds delivered to the account designated by the Company.&#160; If the Company, or its transfer agent (if applicable), shall default on its obligation to
            deliver the Shares on any Agency Settlement Date, the Company shall (i) indemnify and hold the Designated Agent harmless against any loss, claim, damage, or expense (including, without limitation, reasonable legal fees and expenses), as
            incurred, arising out of or in connection with such default by the Company and (ii) pay the Designated Agent any commission, discount or other compensation to which it would otherwise be entitled absent such default.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Principal Transactions.</font>&#160; If the Company wishes to issue and sell the Shares other than as set forth in subsection (a) of this Section 1 (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Principal Transaction</font>&#8221;), the Company will notify the Agents of the proposed terms of such Principal Transaction.&#160; If any Agent, acting as principal, wishes to accept such proposed terms (which it may decline to do for any reason
            in its sole discretion) or, following discussions with the Company, wishes to accept amended terms, the Agent(s) and the Company will enter into an agreement in substantially the form of <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Exhibit B</u></font> hereto (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Terms Agreement</font>&#8221;) that sets forth the terms of such Principal Transaction, including, without limitation, the
            time, date and place of delivery of and payment for the Shares to be sold pursuant to such Principal Transaction (each of such date and each Agency Settlement Date, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Settlement
              Date</font>&#8221;).&#160; The terms set forth in a Terms Agreement shall not be binding on the Company or the Agent(s) unless and until each of the Company and the applicable Agent(s) has executed such Terms Agreement accepting all of such terms.&#160; The
            commitment of the applicable Agent(s) to purchase the Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations and warranties of the Company herein contained and shall be subject to the terms
            and conditions herein set forth.&#160; In the event of a conflict between the terms of this Agreement and the terms of any Terms Agreement, the terms of such Terms Agreement shall control.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Maximum Number of Shares.</font>&#160; Under no circumstances shall the Company propose to any Agent, or any Agent effect, a sale of Shares in an Agency Transaction or a Principal Transaction pursuant to this Agreement
            if such sale would (i) cause the aggregate gross sales proceeds of the Shares sold pursuant to this Agreement to exceed the Maximum Amount, (ii) cause the number of Shares sold to exceed the number of shares of Common Stock available for offer
            and sale under the then effective Registration Statement or (iii) cause the number of Shares sold pursuant to this Agreement to exceed the number of Shares authorized from time to time to be issued and sold pursuant to this Agreement by the
            Company&#8217;s board of directors, or a duly authorized committee thereof, or approved for listing on the Exchange and, in each case referred to in (ii) and (iii), notified to the Agents in writing. In addition, under no circumstances shall the
            Company propose to any Agent, or any Agent effect, a sale of Shares in an Agency Transaction or a Principal Transaction pursuant to this Agreement at a price lower than the minimum price therefor duly authorized from time to time by the Company
            and notified to the Agents in writing. The Agents shall have no responsibility for maintaining records with respect to Shares available for sale under the Registration Statement or for determining the aggregate gross sales price, number or
            minimum price of Shares duly authorized by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Regulation M.</font>&#160; If either party hereto has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the Exchange Act are not satisfied with respect to the Company or
            the Shares, it shall promptly notify the other party and sales of Shares under this Agreement shall be suspended until that or other exemptive provisions have been satisfied in the judgment of each party hereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Material Information.</font> Notwithstanding any other provision of this Agreement, no sales of Shares shall take place, the Company shall not request the sales of any Shares that would be sold and no Agent shall
            be obligated to sell or offer to sell any Shares during any period in which the Company is, or could be deemed to be, in possession of material non-public information with respect to the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Continuing Accuracy of Representations and Warranties.</font> Any obligation of a Designated Agent to use its commercially reasonable efforts to sell the Shares on behalf of the Company as sales agent shall be
            subject to the continuing accuracy of the representations and warranties of the Company herein, to the performance by the Company of its obligations hereunder and to the continuing satisfaction of the conditions specified in Section 4 of this
            Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160; <br>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Representations and Warranties of the Company</u></font>.&#160; The Company represents and warrants to, and covenants with, each Agent as follows:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Effectiveness of Registration.</font>&#160; The Registration Statement and any post-effective amendment thereto have become effective.&#160; The Company has responded to all requests, if any, of the Commission for
            additional or supplemental information.&#160; No stop order suspending the effectiveness of the Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the knowledge of the Company, are
            contemplated or threatened by the Commission.&#160; (i) At the time of filing the Registration Statement, (ii) at the time of the most recent amendment thereto for purposes of complying with Section 10(a)(3) of the Act (whether such amendment was by
            post-effective amendment, incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or form of prospectus) and (iii) at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of
            Rule 163(c) of the Rules and Regulations) made any offer relating to the Shares in reliance on the exemption of Rule 163 of the Rules and Regulations, the Company was and is a &#8220;well-known seasoned issuer&#8221; as defined in Rule 405 of the Rules and
            Regulations.&#160; The Registration Statement is an &#8220;automatic shelf registration statement&#8221;, as defined in Rule 405 of the Rules and Regulations, and the Shares, since their registration on the Registration Statement, have been and remain eligible
            for registration by the Company on such Registration Statement.&#160; The Company has not received from the Commission any notice pursuant to Rule 401(g)(2) of the Rules and Regulations objecting to use of the automatic shelf registration statement
            form and the Company has not otherwise ceased to be eligible to offer and sell the Shares using the Registration Statement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Accuracy of the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus.</font>&#160; (i) At the respective times the Registration Statement and any post-effective amendment thereto became
            effective, (ii) at each deemed effective date with respect to an Agent pursuant to Rule 430B(f)(2) under the Act, (iii) as of each Time of Sale (as defined below), (iv) at each Settlement Date and (v) at all times during such period as the
            Prospectus is required by law to be delivered (whether physically, deemed to be delivered pursuant to Rule 153 or through compliance with Rule 172 of the Rules and Regulations or any similar rule) in connection with sales of the Shares (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Prospectus Delivery Period</font>&#8221;), the Registration Statement complied and will comply in all material respects with the Act and the Rules and Regulations, and did not and will not
            contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.&#160; As of each Time of Sale and each Settlement Date and at all times during
            the Prospectus Delivery Period, the Prospectus, as amended or supplemented, complied and will comply in all material respects with the Act and the Rules and Regulations, and, together with all of the then issued Permitted Free Writing
            Prospectuses, if any, did not and will not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
            misleading.&#160; The Base Prospectus (including any amendment thereto) complied when so filed in all material respects with the Rules and Regulations, and the Prospectus (including the Base Prospectus included therein) delivered to the Agents for
            use in connection with the transactions contemplated by this Agreement is identical to the electronically transmitted copy thereof filed with the Commission on EDGAR, except to the extent permitted by Regulation S-T.&#160; The foregoing
            representations and warranties in this Section 2(b) do not apply to any statements contained in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus in reliance upon and in conformity with information relating to
            the Agents furnished in writing to the Company by such Agent specifically for inclusion in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus (or any amendment or supplement thereto), which constitutes the
            information set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Schedule 2</u></font> hereto.&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Time of Sale</font>&#8221; means, (i) with respect to an
            Agency Transaction, the time of the applicable Agent&#8217;s initial entry into contracts with investors for the sale of such Shares and (ii) with respect to a Principal Transaction, the time of sale of such Shares.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Documents Incorporated by Reference.</font>&#160; The Incorporated Documents, at the time they were or hereafter are filed with the Commission, conformed and will conform in all material respects to the requirements of
            the Act or the Exchange Act, as applicable, and, when read together with the other information in the Prospectus, at the time the Registration Statement and any amendments thereto become effective, as of each Time of Sale and each Settlement
            Date and at all times during the Prospectus Delivery Period, will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they
            were made, not misleading.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Company Not Ineligible Issuer</font>.&#160; (i) At the time of filing the Registration Statement, (ii) at the earliest time that the Company or another offering participant made a <font style="font-family: 'Times New Roman'; font-style: italic;">bona fide</font> offer (within the meaning of Rule 164(h)(2) of the Rules and Regulations) of the Shares and (iii) at the date hereof, the Company was not and is not an &#8220;ineligible issuer&#8221; (as defined in Rule 405
            of the Rules and Regulations).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Free Writing Prospectuses.&#160; </font>Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) of the Rules and Regulations has been, or will be, filed with the Commission in
            accordance with the requirements of the Act and the Rules and Regulations.&#160; Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) of the Rules and Regulations or that was prepared by or on
            behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of the Act and the Rules and Regulations.&#160; Each free writing prospectus, as of its issue date and at all subsequent times
            through the completion of the offer and sale of the Shares or until any earlier date that the Company notified or notifies the Agents, did not, does not and will not include any material information that conflicted, conflicts or will conflict
            with the information contained in the Registration Statement or the Prospectus.&#160; Except for the Permitted Free Writing Prospectuses, if any, the Company has not prepared, used or referred to, and will not, prepare, use or refer to, any free
            writing prospectus.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Due Incorporation; Subsidiaries</font>.&#160; The Company has been duly incorporated, is validly existing as a corporation and is in good standing under the laws of its jurisdiction of incorporation.&#160; The Company has
            full corporate power and authority to own or lease all the assets owned or leased by it and to conduct its business as described in the Registration Statement and the Prospectus.&#160; The Company is duly licensed or qualified to do business in and
            in good standing as a foreign corporation in all jurisdictions in which the nature of the activities conducted by it or the character of the assets owned or leased by it makes such licensing or qualification necessary, except to the extent that
            the failure to be so licensed or qualified or be in good standing would not reasonably be expected to have a material adverse effect on the business, properties, assets, business prospects, condition (financial or otherwise), results of
            operations or capitalization of the Company and its subsidiaries, taken as a whole (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Material Adverse Effect</font>&#8221;).&#160; Each subsidiary has been duly incorporated or formed, is
            validly existing as a corporation, limited liability company or limited partnership and is in good standing under the laws of its jurisdiction of incorporation or formation.&#160; Each subsidiary of the Company has full corporate, limited liability
            company or limited partnership power and authority to own or lease all the assets owned or leased by it and to conduct its business as described in the Registration Statement and the Prospectus.&#160; Each subsidiary of the company is duly licensed
            or qualified to do business in and in good standing as a foreign corporation, limited liability company or limited partnership in all jurisdictions in which the nature of the activities conducted by it or the character of the assets owned or
            leased by it makes such licensing or qualification necessary, except to the extent that the failure to be so licensed or qualified or be in good standing would not reasonably be expected to have a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Capitalization.</font>&#160; The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration Statement and the Prospectus.&#160; The outstanding shares of Common Stock and any other
            outstanding capital stock of the Company have been, and the Shares will be when issued in accordance with this Agreement (in the case of an Agency Transaction) or a Terms Agreement (in the case of a Principal Transaction), duly authorized,
            validly issued, fully paid and non-assessable and will not be subject to any preemptive, first refusal, or similar right.&#160; The description of the Common Stock included or incorporated by reference in the Registration Statement and the
            Prospectus is complete and accurate in all material respects.&#160; Except as described in the Registration Statement and the Prospectus, the Company does not have outstanding any options to purchase, or any rights or warrants to subscribe for, or
            any securities or obligations convertible into, or any contracts or commitments to issue or sell, any shares of capital stock of the Company or of any subsidiary of the Company or any such warrants, convertible securities or obligations.&#160; All
            of the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly authorized and validly issued, are fully paid and non-assessable (except, in the case of any
            foreign subsidiary, for directors&#8217; qualifying shares), are not be subject to any preemptive, first refusal, or similar right, and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security
            interest, restriction on voting or transfer or any other claim of any third party, except as described in the Registration Statement and the Prospectus, arising out of the Gold Sale and Purchase Agreement between Franco-Nevada (Barbados)
            Corporation, Coeur Mexicana, S.A. de C.V., Ocampo Resources, Inc. and Ocampo Services, Inc. dated as of October 2, 2014, or as are not material to the business of the Company or its subsidiaries.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Financial Statements.</font>&#160; (<font style="font-family: 'Times New Roman';">i)</font> The consolidated financial statements of the Company and its subsidiaries (including the related notes thereto) and schedules
            included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus comply in all material respects with the applicable requirements of the Act and the Exchange Act, as applicable, and
            present fairly the financial condition of the Company and its consolidated subsidiaries as of the date(s) indicated and the results of their respective operations and the changes in their respective cash flows for the periods specified; such
            financial statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">GAAP</font>&#8221;) applied on a consistent basis throughout the periods
            covered thereby, except as otherwise disclosed in the financial statement footnotes, and the supporting schedules included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus
            present fairly the information required to be stated therein; and the other financial information included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus has been derived
            from the accounting records of the Company and its subsidiaries and presents fairly the information shown thereby.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Independent Accountant.</font> The accountants who have reported on the financial statements and schedules included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free
            Writing Prospectus (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Accountants</font>&#8221;), are (i) independent accountants with respect to the Company as required by the Act and the Rules and Regulations and by Rule 3600T
            of the Public Company Accounting Oversight Board (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">PCAOB</font>&#8221;), (ii) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01
            of Regulation S-X under the Act, and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn.&#160; Except as described in the
            Prospectus and as preapproved in accordance with the requirements set forth in Section 10A of the Exchange Act, the Accountants have not engaged in any &#8220;prohibited activities&#8221; (as defined in Section 10A of the Exchange Act) on behalf of the
            Company.&#160; The statements included in the Registration Statement with respect to the Accountants pursuant to Rule 509 of Regulation S-K of the Rules and Regulations are true and correct in all material respects.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">[Intentionally Omitted]</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Material Adverse Changes.</font>&#160; Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and the Prospectus, there has not been
            and will not have been a material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in
            the ordinary course of business (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Material Adverse Change</font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Investment Company.</font>&#160; The Company is not, and after giving effect to the offering and sale of the Shares and the use of the proceeds therefrom as described in the Registration Statement and the Prospectus
            will not be an &#8220;investment company&#8221; or an &#8220;affiliated person&#8221; of, or &#8220;promoter&#8221; or &#8220;principal underwriter&#8221; for, an &#8220;investment company,&#8221; as such terms are defined in the Investment Company Act of 1940, as amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Litigation.</font>&#160; Except as set forth in the Registration Statement and the Prospectus, there are no actions, suits or proceedings pending, or to the Company&#8217;s knowledge, threatened against or affecting, the
            Company or any of its subsidiaries or any of their respective officers in their capacity as such, before or by any federal or state court, commission, regulatory body (including, without limitation, the Financial Industry Regulatory Authority,
            Inc. (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">FINRA</font>&#8221;) and the Exchange), administrative agency or other governmental body, in each case whether domestic or foreign, wherein an unfavorable ruling, decision or
            finding would reasonably be expected to have a Material Adverse Effect.&#160; Neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any authorization, approval, order,
            license, certificate, franchise or permit, which revocation or modification would reasonably be expected to have a Material Adverse Effect.&#160; There are no pending investigations known to the Company involving the Company or any of its
            subsidiaries by any governmental agency having jurisdiction over the Company or any of its subsidiaries or their respective businesses or operations, which investigations would reasonably be expected to have a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Necessary Licenses, Compliance with Laws and Regulations and Performance of Obligations and Contracts.</font>&#160; Each of the Company and its subsidiaries has (i) all governmental and other regulatory licenses,
            permits, consents, orders, approvals and other authorizations necessary to carry on its business as described in the Prospectus; (ii) complied in all respects with all laws, regulations and orders applicable to it and its business and (iii)
            performed all obligations required to be performed by it, and is not in default under any indenture, mortgage, deed of trust, voting trust agreement, loan agreement, bond, debenture, note agreement, lease or other agreement or instrument
            (individually, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Contract</font>&#8221; and collectively, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Contracts</font>&#8221;) to which it is a party or by which its
            property is bound or affected, except, in each case, where the failure to do so or where such default would not reasonably be expected to have a Material Adverse Effect.&#160; Each Contract was duly authorized, executed and delivered by the Company
            or the relevant subsidiary of the Company, constitutes valid and binding agreements of the Company or such subsidiary of the Company and are enforceable against the Company or such subsidiary of the Company in accordance with the terms thereof,
            except, in each case, where the failure to do so or where such default would not reasonably be expected to have a Material Adverse Effect.&#160;&#160; To the knowledge of the Company, no other party under any material Contract to which it or its
            subsidiaries is a party is in default in any respect thereunder or has given written, or, to the knowledge of the officers and directors of the Company, oral, notice to the Company, its subsidiaries or any of their respective officers or
            directors of such other party&#8217;s intention to terminate, cancel or refuse to renew any material Contract.&#160; Each of the Company and its subsidiaries is not in violation of any provision of its certificate of incorporation or by-laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Consent of Governmental Body Needed.</font>&#160; No consent, approval, authorization, license, registration, qualification, or order of, or any filing or declaration with, any court or arbitrator or governmental or
            regulatory authority, agency or body is required in connection with the authorization, issuance, transfer, sale or delivery of the Shares by the Company, in connection with the execution, delivery and performance of this Agreement by the
            Company or in connection with a Terms Agreement or the taking by the Company of any action contemplated hereby or thereby, except as have been obtained under the Act and such as may be required under state securities or Blue Sky laws or the
            by-laws and rules of FINRA in connection with the purchase and distribution by the Agents of the Shares to be sold by the Company hereby or thereby.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Agreement Duly Authorized and No Breach of Obligations or Charter.</font>&#160; The Company has full corporate power and authority to enter into this Agreement and each Terms Agreement.&#160; This Agreement has been, and
            any Terms Agreement will have been, duly authorized, executed and delivered by the Company and this Agreement constitutes, and any Terms Agreement will constitute, a valid and binding agreement of the Company enforceable against the Company in
            accordance with the terms hereof or thereof, as the case may be, except as the enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors&#8217; rights
            generally or general equitable principles.&#160; The execution and delivery by the Company of this Agreement and any Terms Agreement and the performance of this Agreement and any Terms Agreement, the consummation of the transactions contemplated
            hereby and thereby, and the application of the net proceeds from the offering and sale of the Shares to be sold by the Company in the manner set forth in the Prospectus under &#8220;Use of Proceeds&#8221; do not and will not (i) violate the certificate of
            incorporation or by-laws of the Company or any subsidiary of the Company or (ii) result in the creation or imposition of any lien, charge or encumbrance upon any of the assets of the Company or any subsidiary of the Company pursuant to the
            terms or provisions of, or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or give any other party a right to terminate any of its obligations under, or result in the acceleration of any
            obligation under any Contract to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries or any of its properties is bound or affected, or violate or conflict with any judgment, ruling, decree,
            order, statute, rule or regulation of any court or other governmental agency or body applicable to the business or properties of the Company or any of its subsidiaries (except for such violations, breaches or defaults or liens, charges or
            encumbrances that would not reasonably be expected to have a Material Adverse Effect).&#160; This Agreement conforms in all material respects to the description thereof contained in the Registration Statement, the Prospectus and any Permitted Free
            Writing Prospectus.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Documents Described in Registration Statement.</font>&#160; There is no document or Contract of a character required to be described or incorporated by reference in the Registration Statement or the Prospectus or to be
            filed as an exhibit to the Registration Statement that is not described or filed as required.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Statistical and Market Data.</font>&#160; All statistical or market-related data included in the Registration Statement or the Prospectus are based on or derived from sources that the Company believes to be reliable
            and accurate, and the Company has obtained the written consent to the use of such data from such sources to the extent required.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Price Stabilization or Manipulation.</font>&#160; Neither the Company nor any of its directors, officers or controlling persons has taken, directly or indirectly, any action intended to cause or result in, or which
            might reasonably be expected to cause or result in, or which has constituted, stabilization or manipulation, under the Act or otherwise, of the price of any security of the Company to facilitate the sale or resale of the Shares.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Registration Rights.</font>&#160; No holder of securities of the Company has rights to register any securities of the Company as a result of the filing of the Registration Statement or Prospectus or consummation of
            the transactions contemplated hereby, except for rights that have been duly waived by such holder, have expired or have been fulfilled by registration prior to the date of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Stock Exchange Listing.</font>&#160; Prior to the first Settlement Date hereunder, the Shares will be duly authorized for listing on the Exchange, subject only to notice of issuance. The Company is not the subject of a
            de-listing or any other order preventing or suspending trading of any securities of the Company issued by the Exchange, and the Company is, to its knowledge, not aware of any such order being contemplated or threatened by the Exchange.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Labor Matters.</font>&#160; Except as set forth in the Registration Statement or Prospectus, neither the Company nor any of its subsidiaries:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">is a party to any collective bargaining
            agreement; or is subject to any application for certification or, to the knowledge of the Company, threatened or apparent union-organizing campaigns for employees not covered under a collective bargaining agreement, except where such
            application or union-organizing campaigns would not, individually or in the aggregate, have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">is involved in any labor strike,
            lock-out, slowdown or work stoppage, except where the dispute would not, individually or in the aggregate, have a Material Adverse Effect, and, to the knowledge of the Company, no such dispute is threatened;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">is subject to any claim for wrongful
            dismissal, constructive dismissal or any other tort claim, actual or, to the knowledge of the Company, threatened, or any litigation actual, or to the knowledge of the Company, threatened, relating to employment or termination of employment of
            employees or independent contractors, except for such claims or litigation which individually or in the aggregate would not be reasonably expected to have a Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">has entered into any written or oral
            agreement or understanding providing for severance or termination payments to any named executive officer (as such term is used in Regulation S-K, Item 402(a)(3)) in connection with the termination of their position or their employment as a
            direct result of a change in control of the Company; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">is in violation or has violated any
            applicable laws with respect to employment and labor, including, but not limited to, employment and labor standards, occupational health and safety, employment equity, pay equity, workers&#8217; compensation, human rights, labor relations and
            privacy, and there are no current, pending, or to the knowledge of the Company, threatened proceedings before any court, agency, board or tribunal with respect to any of the areas listed in this subsection 2(u)(v), except where the violation or
            proceeding would not reasonably be expected to have a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Taxes.</font>&#160; Except as set forth in the Registration Statement or Prospectus, and except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">each of the Company and its
            subsidiaries has duly and timely filed all federal, state and foreign income and other tax returns required to be made or prepared by it (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Tax Return</font>&#8221; and
            collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Tax Returns</font>&#8221;), with the appropriate governmental entity or authority and has, in all material respects, completely and correctly reported all income and
            all other amounts or information required to be reported thereon;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">has (A) duly and timely paid all Taxes
            due and payable by it, (B) duly and timely withheld all Taxes and other amounts required by applicable laws to be withheld by it and has duly and timely remitted to the appropriate governmental entity or authority such Taxes and other amounts
            required by applicable laws to be remitted by it, and (C) duly and timely collected all amounts on account of sales or transfer taxes, including goods and services, harmonized sales and provincial or territorial sales taxes, required by
            applicable laws to be collected by it and has duly and timely remitted to the appropriate governmental entity or authority any such amounts required by applicable laws to be remitted by it;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">the charges, accruals and reserves for
            Taxes reflected on the financial statements referred to in subsection (h) of this Section 2 (whether or not due and whether or not shown on any Tax Return, but excluding any provision for deferred income taxes) are, in the opinion of the
            Company, adequate under GAAP, as applicable, to cover Taxes with respect to the Company and the subsidiaries accruing through the date hereof;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">there are no proceedings,
            investigations, audits, assessments, reassessments or claims now pending or, to the knowledge of the Company, threatened against any of the Company or the subsidiaries that propose to assess Taxes in addition to those reported in the Tax
            Returns; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">no waiver of any statutory limitation
            period with respect to Taxes has been given to, or requested by, a taxing authority with respect to the Company or any of the subsidiaries.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For the purposes of this Agreement, <font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Tax&#8221;</font> and <font style="font-family: 'Times New Roman'; font-weight: bold;">&#8220;Taxes&#8221;</font> means all taxes, assessments, charges, dues, duties, rates, fees, imposts, levies and similar charges of any kind lawfully levied, assessed or imposed by any governmental entity or authority, including all
        income taxes (including any tax on or based upon net income, gross income, income as specially defined, earnings, profits or selected items of income, earnings or profits) and all capital taxes, gross receipts taxes, environmental taxes, sales
        taxes, use taxes, <font style="font-family: 'Times New Roman'; font-style: italic;">ad valorem</font> taxes, value added taxes, transfer taxes (including, without limitation, taxes relating to the transfer of interests in real property or entities
        holding interests therein), franchise taxes, license taxes, withholding taxes, payroll taxes, employment taxes, pension plan premiums, excise, severance, social security, workers' compensation, employment insurance or compensation taxes or premium,
        stamp taxes, occupation taxes, premium taxes, property taxes, harmonized sales taxes, windfall profits taxes, alternative or add-on minimum taxes, goods and services tax, customs duties or other taxes, fees, imports, assessments or charges of any
        kind whatsoever, together with any interest and any penalties or additional amounts imposed by any taxing authority (domestic (whether provincial, federal, state or local) or foreign) on such entity, and any interest, penalties, additional taxes
        and additions to tax imposed with respect to the foregoing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Insurance.</font>&#160; Each of the Company and its subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as it believes is adequate for the conduct of its business and the value of
            its properties and is customary for companies engaged in similar industries, and all such insurance is in full force and effect.&#160; The Company has no reason to believe that it and its subsidiaries will not be able to (i) renew their existing
            insurance coverage as and when such policies expire or (ii) obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct their business as currently conducted or proposed to be conducted and at a cost that
            would not, individually or in the aggregate, result in a Material Adverse Effect.&#160; Neither the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for which it has applied where such denial would or
            has resulted in a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Employee Benefit Plans.</font>&#160; Neither the Company nor any of its subsidiaries maintains or contributes to, or has any liability with respect to, a defined benefit plan as defined in Section 3(35) of the Employee
            Retirement Income Security Act of 1974, as amended (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">ERISA</font>&#8221;).&#160; No plan maintained or contributed to by the Company that is subject to ERISA (an &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">ERISA Plan</font>&#8221;) (or any trust created thereunder) has engaged in a &#8220;prohibited transaction&#8221; within the meaning of Section 406 of ERISA or Section 4975 of the Internal Revenue Code of 1986, as amended
            (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Code</font>&#8221;) that could subject the Company or any of its subsidiaries to any material tax penalty on prohibited transactions and that has not adequately been corrected.&#160;
            Each ERISA Plan is in compliance with all operational, reporting, disclosure and other requirements of the Code and ERISA as they relate to such ERISA Plan, except for any noncompliance that would not result in the imposition of a material tax
            or monetary penalty.&#160; With respect to each ERISA Plan that is intended to be &#8220;qualified&#8221; within the meaning of Section 401(a) of the Code, either (i) a determination or opinion letter has been issued by the Internal Revenue Service stating that
            such ERISA Plan and the attendant trust are qualified thereunder or (ii) the remedial amendment period under Section 401(b) of the Code with respect to the establishment of such ERISA Plan has not ended and a determination letter application
            will be filed with respect to such ERISA Plan prior to the end of such remedial amendment period.&#160; Neither the Company nor any of its subsidiaries has any unsatisfied liability with respect to a &#8220;multiemployer plan,&#8221; as defined in Section 3(37)
            of ERISA.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Title to Intellectual Property.</font>&#160; Except as described in the Registration Statement and the Prospectus, each of the Company and its subsidiaries owns, is licensed or otherwise has adequate rights to use
            Company technology (including, without limitation, patented, patentable and unpatented inventions and unpatentable proprietary or confidential information, systems or procedures), designs, processes, trademarks, trade secrets, know how,
            copyrights and other works of authorship, computer programs and technical data and information that are or could reasonably be expected to be material to its business as currently conducted or as currently proposed to be conducted.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Title to Real and Personal Property.</font>&#160; The Company and each of its subsidiaries has good and marketable title to all properties and assets described or incorporated by reference in the Prospectus as being
            owned respectively by it, free and clear of all liens, charges, encumbrances or restrictions (other than liens, charges, encumbrances or restrictions arising out of the Gold Sale and Purchase Agreement between Franco-Nevada (Barbados)
            Corporation, Coeur Mexicana, S.A. de C.V., Ocampo Resources, Inc. and Ocampo Services, Inc. dated as of October 2, 2014), except as described in the Registration Statement and the Prospectus or as are not material to the business of the Company
            or its subsidiaries.&#160; Each of the Company and its subsidiaries has valid, subsisting and enforceable leases for the properties described or incorporated by reference in the Prospectus as leased by it, with such exceptions as are not material
            and do not materially interfere with the use made and proposed to be made of such properties by the Company and its subsidiaries.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Mining Rights</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Except as set forth in the Registration
            Statement, the Palmarejo mine and complex, the Rochester mine, the Kensington mine, the Wharf mine, and the Silvertip mine, each as described in the Registration Statement and the Prospectus (each a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Material Property</font>&#8221; and collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Material Properties</font>&#8221;), are the only resource properties that are currently material to the Company in
            which the Company or the subsidiaries have an interest.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company directly or through its
            subsidiaries, holds an interest in fee or freehold title, mining leases, mining concessions, mining claims, exploration permits, prospecting permits, participant interests, conventional property agreements, or proprietary interests or rights,
            recognized in the jurisdiction in which the Material Properties are located, in respect of the ore bodies and minerals located on the Material Properties in which the Company (through the applicable subsidiary) has an interest under valid,
            subsisting and enforceable title documents or other recognized and enforceable agreements, contracts, arrangements or understandings, sufficient to permit the Company (through the applicable subsidiary) to explore for and exploit the minerals
            relating thereto, and all such agreements, contracts, arrangements or understandings in connection with the Material Properties are valid and subsisting and enforceable in accordance with their terms.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">All material concessions, leases,
            property agreements and contracts, claims and permits relating to the Material Properties in which the Company (through the applicable subsidiary) has an interest or right have been validly granted, located, approved, executed and recorded or
            filed in accordance with all applicable laws and are valid, subsisting and enforceable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as disclosed in the Registration
            Statement or the Prospectus, the Company (through the applicable subsidiary) has all necessary surface rights, access rights and other necessary rights and interests relating to the Material Property in which the Company (through the applicable
            subsidiary) has an interest granting the Company (through the applicable subsidiary) the right and ability to explore for and exploit minerals, ore and metals for development and production purposes as are appropriate in view of the rights and
            interest therein of the Company or the applicable subsidiary, with only such exceptions as do not materially interfere with the current use made by the Company or the applicable subsidiary of the rights or interest so held, and each of the
            proprietary interests or rights and each of the agreements, contracts, arrangements or understandings and obligations relating thereto referred to above is currently in good standing in all material respects in the name of the Company or the
            applicable subsidiary.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as disclosed in the Prospectus,
            the Company and the subsidiaries do not have any responsibility or obligation to pay any commission, royalty, license, fee, assessment or similar payment to any person with respect to the property rights thereof, except where such fee or
            payment would not reasonably be expected to have a Material Adverse Effect, either individually<font style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">&#160;</font>or in the aggregate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">The Company and the subsidiaries have
            identified all the material permits, certificates, and approvals (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Permits</font>&#8221;) which are or will be required for the exploration, development and eventual
            or actual operation of the Material Properties, which Permits include but are not limited to mine and reclamation permits, access and use grants and permits, environmental assessment certificates, water appropriation and use permits, licenses
            and applications, land tenures, rezoning or zoning variances and other necessary local, provincial, state and federal approvals; and, except as disclosed in the Registration Statement or the Prospectus, the appropriate Permits have either been
            received, applied for, or the processes to obtain such Permits have been or will in due course be initiated by the Company or the applicable subsidiaries; and, except as disclosed in the Registration Statement or the Prospectus, neither the
            Company nor the applicable subsidiaries know of any issue or reason why the Permits should not be approved and obtained in the ordinary course.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">All assessments or other work required
            to be performed in relation to the material mining claims and mining rights of the Company and the applicable subsidiary in order to maintain their respective interests therein, if any, have been performed to date and, except as disclosed in
            the Registration Statement or the Prospectus, the Company and the applicable subsidiary have complied in all respects with all applicable laws in this regard as well as with regard to legal and contractual obligations to third parties in this
            regard except in respect of mining claims and mining rights that the Company and the applicable subsidiary intend to abandon or relinquish and except for any non-compliance which would not either individually or in the aggregate have a Material
            Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Mining Practice</font>.&#160; Except as disclosed in the Registration Statement and the Prospectus, all mining operations by the Company and its subsidiaries on the Material Properties have for the past five years been
            conducted with the exercise of reasonable diligence, skill, care and prudence for mining operations in similar locations under similar circumstances.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Technical Reports.&#160; </font><font style="font-family: 'Times New Roman'; font-weight: bold;"><u> Schedule 2(cc)</u></font> sets out each applicable current technical report relating to the Material Properties (the
            &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reports</font>&#8221;).&#160; Each Report was at the time of filing compliant, in all material respects, with the requirements of the provisions of subpart 1300 of Regulation S-K under the
            Securities Exchange Act of 1934, as amended (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">SK-1300</font>&#8221;).&#160; All scientific and technical information disclosed in the Registration Statement and Prospectus: (i) is based upon
            information prepared by or under the supervision of, or approved by, a &#8220;qualified person&#8221; (as such term is defined in SK-1300) and (ii) was true, complete and accurate in all material respects at the time of filing.&#160; The Company made available
            to the respective authors thereof prior to the issuance of all of the Reports, for the purpose of preparing the Reports, as applicable, all information requested, and no such information contained any misrepresentation as at the time the
            relevant information was made available.&#160; The Reports, as of their respective dates, accurately and completely set forth all material facts relating to the Material Properties, and as of the date hereof and the date of the Prospectus, there is
            no new material scientific or technical information concerning any of the Material Properties not included in the Reports.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Environmental Matters</font>.&#160; Except as described in the Registration Statement and the Prospectus, and except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
            Effect:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">each of the Company and its
            subsidiaries is in compliance in all material respects with all applicable federal, provincial, state, municipal and local laws, statutes, ordinances, regulations and orders, directives and decisions rendered by any ministry, department or
            administrative or regulatory agency, whether domestic or foreign, in each case, relating to the protection of the environment, the processing, use, treatment, storage, disposal, discharge, transport or handling of any pollutants, contaminants,
            chemicals, substances or industrial wastes classified as toxic or hazardous to human health or the environment (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Hazardous Substances</font>&#8221;), or with respect to Hazardous
            Substances, occupational health and safety (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Environmental Laws</font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">the Company and its subsidiaries have
            all permits, licenses, authorizations and approvals required under any applicable Environmental Law (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Environmental Permits</font>&#8221;) and are in compliance with all terms and
            conditions of each Environmental Permit;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">there are no pending or, to the
            Company&#8217;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, claims, liens, investigation or proceedings against the Company or any of its subsidiaries, relating to any alleged violation of or liability under
            Environmental Law;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">neither the Company nor any of
            subsidiary has failed to report to the proper governmental authority the occurrence of any event which is required to be so reported by any Environmental Laws;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">neither the Company nor any of its
            subsidiaries is subject to (A) any Environmental Laws that require or may require any material work, repairs, construction, change in business practices or operations, or any expenditures, including capital expenditures, for facility upgrades
            to mitigate, control, or limit releases of Hazardous Substances into the environment, environmental investigation and remediation, or corrective actions, except with respect to any remediation obligations required as part of mine reclamation
            and covered under existing reclamation surety bonds or pursuant to or in accordance with Environment Permits; (B) any written demand, written notice of default, summons, notice of judgment or commencement of proceedings with respect to any
            alleged violation of or liability arising under Environmental Laws; or (C) any outstanding obligations to remedy, pay compensation, or make any payment in the nature of a fine in relation to any violation of Environmental Laws; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">there are no events or circumstances
            that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or any of its subsidiaries
            pursuant to any Environmental Laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Trademarks.</font>&#160; Each of the Company and its subsidiaries owns, or is licensed or otherwise has the full right to use, all material trademarks and trade names that are used in or reasonably necessary for the
            conduct of their respective businesses as described in the Prospectus.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Protection of Intellectual Property.</font>&#160; Each of the Company and its subsidiaries has taken reasonable security measures to protect the secrecy, confidentiality and value of all their Intellectual Property in
            all material respects.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(gg)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Related Party Transactions.</font>&#160; There are no business relationships or related party transactions involving the Company or any other person required to be described in the Prospectus that have not been
            described or incorporated therein by reference. Without limiting the generality of the immediately preceding sentence, no relationship, direct or indirect, exists between or among the Company or any subsidiary of the Company on the one hand,
            and the directors, officers, stockholders, customers or suppliers of the Company on the other hand, that is required to be described in the Prospectus and that is not so described or incorporated therein by reference.&#160; Within the last three
            years, the Company has not, directly or indirectly, extended or maintained credit, arranged to extend credit, or renewed any extension of credit, in the form of a personal loan, to or for any director or executive officer of the Company, or to
            or for any family member or affiliate of any director or executive officer of the Company in violation of applicable laws, including Section 13(k) of the Exchange Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(hh)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Prohibition on its Subsidiaries from Paying Dividends or Making Other Distributions.</font>&#160; No subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the
            Company, from making any other distribution on its capital stock, from repaying to the Company any loans or advances from the Company or from transferring any of its property or assets to the Company or any other subsidiary of the Company of
            the Company, except as described in the Registration Statement and the Prospectus.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-style: italic;">Controls and
            Procedures.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Disclosure Controls and Procedures.&#160; </font>The Company has established and maintains disclosure controls and procedures (as such term is defined in Rule 13a-15 and 15d-15 under the Exchange Act), that (A) are
            designed to ensure that material information required to be disclosed by the Company in the reports it files and submits under the Exchange Act is accumulated and communicated to the management of the Company, including its principal executive
            officer and its principal financial officer, as appropriate, to allow timely decisions regarding required disclosure to be made; (B) provide for the periodic evaluation of the effectiveness of such disclosure controls and procedures as of the
            end of the period covered by the Company&#8217;s most recent annual or quarterly report filed with the Commission; and (C) are effective in all material respects to perform the functions for which they were established.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Internal Control Over Financial Reporting and Internal Accounting Controls</font>.&#160; Except as disclosed in the Registration Statement, the Company maintains (i) &#8220;effective internal control over financial
            reporting&#8221; as defined in, and in compliance with, Rules 13a-15 and 15d-15 under the Exchange Act, and (ii) a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions are executed in accordance with
            management&#8217;s general or specific authorizations; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (C) access to assets is permitted only in
            accordance with management&#8217;s general or specific authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (E)
            the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the required information and is prepared in accordance
            with the Commission's rules and guidelines applicable thereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Material Weakness in Internal Controls.&#160; </font>Except as disclosed in the Registration Statement, the Company is not aware of (i) any material weakness in the Company&#8217;s internal control over financial
            reporting (whether or not remediated); (ii) any change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial
            reporting; or (iii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(jj)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Off-Balance Sheet Transactions.</font>&#160; Except as described in the Registration Statement and the Prospectus, there are no material off-balance sheet transactions (including, without limitation, transactions
            related to, and the existence of, &#8220;variable interest entities&#8221; within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 810), arrangements, obligations (including, without limitation, contingent
            obligations), or any other relationships with unconsolidated entities or other persons, that may have a material current or future effect on the Company&#8217;s financial condition, changes in financial condition, results of operations, liquidity,
            capital expenditures, capital resources, or significant components of revenues or expenses.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(kk)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Audit Committee.</font>&#160; The Company&#8217;s board of directors (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Board of Directors</font>&#8221;) has validly appointed an audit committee whose
            composition satisfies the requirements of Section 10A of, and Rule 10A-3 under, the Exchange Act, and the Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of&#160; Section 10A of, and Rule 10A-3
            under, the Exchange Act. As of the date of this Agreement, neither the Board of Directors nor the audit committee has been informed, nor is any director of the Company aware, of (i) any significant&#160; deficiency in the design or operation of the
            Company&#8217;s internal control over financial reporting which is reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial data or any material weakness in the Company&#8217;s internal controls; or
            (ii) any fraud, whether or not material, that involves management or other employees of the Company who have a significant role in the Company&#8217;s internal controls.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ll)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Sarbanes-Oxley.</font>&#160; The Company is, and after giving effect to the offering and sale of the Shares will be, in compliance in all material respects with all applicable effective provisions of the Sarbanes-Oxley
            Act of 2002 and the rules and regulations of the Commission promulgated thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(mm)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">[Intentionally Omitted]</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(nn)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Unlawful Contributions or Payments.</font>&#160; Neither the Company nor any of its subsidiaries, nor any director, or executive officer of the Company, nor, to the knowledge of the Company, any director, officer,
            agent, employee or representative of the Company or its subsidiaries or other person associated with or acting on behalf of the Company or its subsidiaries, has (i) used any corporate funds for any unlawful contribution, gift, entertainment or
            other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment of corporate funds or benefit to any foreign or domestic government
            or regulatory official or employee, including, without limitation, of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or
            any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any applicable law or
            regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offense under any other applicable anti-bribery or anti-corruption laws; or (iv) made, offered,
            agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company has
            instituted, maintained and enforced, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(oo)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Compliance with Anti-Money Laundering Laws.</font> The operations of the Company and its subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting
            requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to
            Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable money laundering statutes of all jurisdictions in which the Company and its subsidiaries conduct business, the rules and regulations thereunder and any related
            or similar rules, regulations or guidelines, issued, administered or enforced by any governmental or regulatory agency (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Money Laundering Laws</font>&#8221;), and no
            action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company,
            threatened.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(pp)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Conflicts with Sanctions Laws</font>.&#160; Neither the Company nor any of its subsidiaries, nor any director or executive officer of the Company, nor, to the knowledge of the Company, any director, officer, agent,
            employee or representative of the Company or its subsidiaries, affiliates or other person associated with or acting on behalf of the Company or its subsidiaries is currently the subject or target of any sanctions administered or enforced by the
            U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">OFAC</font>&#8221;) or the U.S. Department of State and including,
            without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Sanctions</font>&#8221;), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including,
            without limitation, Cuba, Iran, North Korea, Sudan, Syria and Crimea (each, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Sanctioned Country</font>&#8221;); and the Company will not directly or indirectly use the proceeds of the
            offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at
            the time of such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person
            (including any person participating in the transaction, whether as agent, principal, advisor, investor or otherwise) of Sanctions.&#160; For the past five years, the Company and its subsidiaries have not knowingly engaged in, are not now knowingly
            engaged in, and will not engage in, any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(qq)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Brokers and Finders</font>.&#160; Neither the Company nor any of its subsidiaries is party to any contract, agreement or understanding with any person (other than this Agreement) that would reasonably be expected to
            give rise to a valid claim against the Company, any subsidiary of the Company or the Agents for a brokerage commission, finder&#8217;s fee or like payment in connection with the offering and sale of the Shares.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(rr)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Forward-Looking Statements</font>.&#160; No forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) included or incorporated by reference in the Registration
            Statement, the Prospectus or any Permitted Free Writing Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ss)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">XBRL</font>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the Prospectus fairly presents the information called for in all
            material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Any certificate signed by any officer of the Company and delivered to the Agents or to counsel for the Agents shall be deemed a representation and
        warranty by the Company, as the case may be, to the Agents as to the matters covered thereby.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Agreements of the Company</u></font>.&#160; The Company covenants and agrees with each Agent as follows:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Amendments and Supplements to the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus</font>.&#160; Other than with respect to any reports or documents and any preliminary or definitive
            proxy or information statement required to be filed by the Company with the Commission in order to comply with the Exchange Act, the Company shall not, during the Prospectus Delivery Period, amend or supplement the Registration Statement, the
            Prospectus or any Permitted Free Writing Prospectus, unless a copy of such amendment or supplement thereto (or such document) shall first have been submitted to the Agents within a reasonable period of time prior to the filing or, if no filing
            is required, the use thereof and the Agents shall not have objected thereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Material Misstatements or Omissions and Other Compliance with Applicable Law.&#160; </font>If, after the date hereof and during the Prospectus Delivery Period, any event or development shall occur or condition shall
            exist as a result of which the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
            statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend or supplement the Prospectus or any Permitted Free Writing Prospectus, or to file any document in order to
            comply with the Act or the Exchange Act, in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if in the reasonable opinion of the Agents it is otherwise necessary to amend or
            supplement the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus or to file any document in order to comply with the Act or the Exchange Act, including, without limitation, in connection with the delivery of the
            Prospectus, the Company shall promptly (i) notify the Agents of any such event, development or condition (and confirm such notice in writing) and (ii)(x) prepare (subject to subsections (a) and (g) of this Section 3) an amendment or supplement
            to the Prospectus or such Permitted Free Writing Prospectus, necessary in order to make the statements in the Prospectus or such Permitted Free Writing Prospectus as so amended or supplemented, in the light of the circumstances under which they
            were made, not misleading or so that the Registration Statement, the Prospectus or such Permitted Free Writing Prospectus, as amended or supplemented, will comply with the Act or the Exchange Act, (y) file with the Commission such amendment,
            supplement or document in order to comply with the Act or the Exchange Act (and use its best efforts to have such amendment or supplement to be declared effective as soon as possible) and (z) furnish at its own expense to the Agents as many
            copies as the Agents may reasonably request of such amendment, supplement or document. The Company will comply with the Act, the Rules and Regulations, the Exchange Act and the rules and regulations promulgated under the Exchange Act so as to
            permit the completion of sales of Shares as contemplated in this Agreement and in the Registration Statement and the Prospectus.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Notifications to the Agents.</font>&#160; The Company shall notify the Agents promptly, and shall confirm such notice in writing, (i) when any post-effective amendment to the Registration Statement becomes effective,
            (ii) of any request by the Commission for an amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus or for additional information, (iii) of the commencement by the Commission or by any
            state securities commission of any proceedings for the suspension of the qualification of any of the Shares for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose, including,
            without limitation, the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or the initiation of any proceedings for such purposes or the threat
            thereof, (iv) of the happening of any event during the Prospectus Delivery Period that in the judgment of the Company makes any statement made in the Registration Statement or the Prospectus untrue or that requires the making of any amendment
            or supplement to the Prospectus or any Permitted Free Writing Prospectus in order to make the statements therein, in the light of the circumstances in which they were made, not misleading and (v) of receipt by the Company or any representative
            of the Company of any other communication from the Commission relating to the Company, the Registration Statement, the Prospectus, any Permitted Free Writing Prospectus or any preliminary prospectus.&#160; If at any time the Commission shall issue
            any such stop order suspending the effectiveness of the Registration Statement, the Company shall use its best efforts to obtain the withdrawal of such order at the earliest possible moment.&#160; In connection with the offer and sale of the Shares
            pursuant to the Registration Statement, the Company shall use its best efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to Rules 424(b), 430A, 430B, 430C and 462(b) of the Rules and
            Regulations and to notify the Agents promptly of all such filings.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Executed Registration Statements.</font>&#160; The Company shall furnish to the Agents, without charge, an electronic copy of the signed Registration Statement and of any post-effective amendment thereto, including
            financial statements and schedules, and all exhibits thereto (including any document filed under the Exchange Act that is deemed to be incorporated by reference into the Prospectus).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Undertakings.</font>&#160; The Company shall comply with all the provisions of any undertakings contained or required to be contained in the Registration Statement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Prospectus.</font>&#160; The Company shall furnish to the Agents, without charge, as many copies of the Prospectus and any amendment or supplement thereto as the Agents may reasonably request (to the extent not
            previously delivered or filed on EDGAR) via electronic mail in &#8220;.pdf&#8221; format and, at the Agents&#8217; request, to furnish copies of the Prospectus to the Exchange and each other exchange or market on which sales of the Shares were or are expected to
            be effected, in each case, as may be required by the rules or regulations of the Exchange or such other exchange or market.&#160; The Company consents to the use of the Prospectus and any amendment or supplement thereto by the Agents during the
            Prospectus Delivery Period.&#160; If any Agent is required to deliver, under the Act (whether physically, deemed to be delivered pursuant to Rule 153 or through compliance with Rule 172 under the Act or any similar rule), a prospectus relating to
            the Shares after the nine-month period referred to in Section 10(a)(3) of the Act, or after that time a post-effective amendment to the Registration Statement is required pursuant to Item 512(a) of Regulation S-K under the Act, then, upon the
            request of such Agent, and at the Company&#8217;s own expense, the Company shall prepare and deliver to such Agent as many copies as such Agent may request of an amended Registration Statement or amended and supplemented Prospectus complying with
            Item 512(a) of Regulation S-K or Section 10(a)(3) of the Act, as the case may be.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Permitted Free Writing Prospectuses.&#160; </font>The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Agents, shall not make, any offer relating to the Shares that
            would constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 of the Rules and Regulations, which is required to be retained by the Company under Rule 433 of the Rules and Regulations; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that the prior written consent of the Agents hereto shall be deemed to have been given in respect of each of the free writing prospectuses set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Schedule 3</u></font> hereto.&#160; Any such free writing prospectus consented to by the Agents is herein referred to as a &#8220;Permitted Free Writing Prospectus.&#8221;&#160; The Company represents and agrees that (i) it has treated and
            shall treat, as the case may be, each Permitted Free Writing Prospectus as a &#8220;free writing prospectus&#8221; as defined in Rule 405 of the Rules and Regulations and (ii) it has complied and shall comply, as the case may be, with the requirements of
            Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including, without limitation, in respect of timely filing with the Commission, legending and record keeping.&#160; The Company agrees not to take any action that
            would result in any Agent or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on behalf of such Agent that such Agent otherwise would not have been required to file thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Registration Statement Renewal Deadline.&#160; </font>If, immediately prior to the third anniversary of the initial effective date of the Registration Statement relating to the Shares (the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Renewal Deadline</font>&#8221;), any of the Shares remain unsold by the Agents, the Company shall prior to the Renewal Deadline (i) file, if it has not already done so (subject to subsection (a) of this
            Section 3), a new shelf registration statement relating to the Shares, in a form reasonably satisfactory to the Agents, (ii) use its best efforts to cause such registration statement to be declared effective within 60 days after the Renewal
            Deadline (if the Company is not then eligible to file an automatic shelf registration statement) and (iii) take all other action necessary or appropriate to permit the public offering and sale of the Shares to continue as contemplated herein
            and in the expired registration statement relating to the Shares.&#160; References herein to the Registration Statement relating to the Shares shall include such new shelf registration statement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Notice of Inability to Use Automatic Shelf Registration Statement Form.&#160; </font>If, at any time when the Shares remain unsold by the Agents, the Company receives from the Commission a notice pursuant to Rule
            401(g)(2) of the Rules and Regulations or otherwise ceases to be eligible to use the Registration Statement for the offer and sale of the Shares, the Company shall (i) promptly notify each Agent, (ii) promptly file a new registration statement
            or post-effective amendment to the existing Registration Statement on the proper form relating to the Shares, in a form reasonably satisfactory to each Agent and subject to subsection (a) of this Section 3, (iii) use its best efforts to cause
            such registration statement or post-effective amendment to be declared effective as soon as practicable, and (iv) promptly notify each Agent upon such effectiveness.&#160; The Company shall take all other action necessary or appropriate to permit
            the public offering and sale of the Shares to continue as contemplated herein and in the Registration Statement that was the subject of the notice pursuant to Rule 401(g)(2) or for which the Company has otherwise become ineligible to use.&#160;
            References herein to the Registration Statement relating to the Shares shall include such new registration statement or post-effective amendment, as the case may be.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Filing Fees</font>.&#160; The Company agrees to pay the required Commission filing fees relating to the Shares within the time required by Rule 456(b)(1) without regard to the proviso therein and otherwise in
            accordance with Rules 456(b) and 457(r).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Compliance with Blue Sky Laws.</font>&#160; The Company shall cooperate with the Agents and counsel therefor in connection with the registration or qualification (or the obtaining of exemptions therefrom) of the Shares
            for the offering and sale under the securities or Blue Sky laws of such jurisdictions as the Agents may request, and to continue such registration or qualification in effect so long as necessary under such laws for the distribution of the
            Shares; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that in no event shall the Company be obligated to qualify to do
            business in any jurisdiction where it is not now so qualified or to take any action which would subject it to general service of process in any jurisdiction where it is not now so subject (except service of process with respect to the offering
            and sale of the Shares).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Delivery of Financial Statements.</font>&#160; During the period of five years commencing on the later of the date hereof and the effective date of the Registration Statement for the distribution of the Shares, the
            Company shall furnish to each Agent (to the extent not available on EDGAR) copies of such financial statements and other periodic and special reports as the Company may from time to time distribute generally to the holders of any class of its
            capital stock, and a copy of each annual or other report it shall be required to file with the Commission.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Availability of Earnings Statements.</font>&#160; The Company shall make generally available to holders of its securities and each Agent as soon as may be practicable but in no event later than the last day of the
            fifteenth full calendar month following the date hereof, an earnings statement (which need not be audited but shall be in reasonable detail) covering the period of 12 months commencing after the date hereof, and satisfying the provisions of
            Section 11(a) of the Act (including Rule 158 of the Rules and Regulations).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Reimbursement of Certain Expenses.</font>&#160; Whether or not any of the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company shall pay, or reimburse if paid by any
            Agent, all costs and expenses incident to the performance of the obligations of the Company under this Agreement, including, without limitation, costs and expenses of or relating to (i) the preparation, printing and filing of the Registration
            Statement and exhibits to it, each preliminary prospectus, each Permitted Free Writing Prospectus, the Prospectus and any amendment or supplement to the Registration Statement or the Prospectus (including the filing fees payable to the
            Commission relating to the Shares within the time required by Rule 456 of the Rules and Regulations), (ii) the preparation and delivery of certificates representing the Shares, (iii) the printing of this Agreement, (iv) furnishing (including
            costs of shipping, mailing and courier) such copies of the Registration Statement, the Prospectus, any preliminary prospectus and any Permitted Free Writing Prospectus, and all amendments and supplements thereto, as may be requested for use in
            connection with the offering and sale of the Shares by the Agents, (v) the listing of the Shares on the Exchange, (vi) any filings required to be made by the Agents with FINRA, and the reasonable fees, disbursements and other charges of counsel
            for the Agents in connection therewith up to $15,000, (vii) the registration or qualification of the Shares for offer and sale under the Act and the securities or Blue Sky laws of such jurisdictions designated pursuant to subsection (k) of this
            Section 3, including the fees, disbursements and other charges of counsel to the Agents in connection therewith, and, if requested by the Agents, the preparation and printing of preliminary, supplemental and final Blue Sky or Legal Investment
            memoranda, (viii) counsel to the Company, (ix) The Depository Trust Company and any other depositary, transfer agent or registrar for the Shares, (x) the Accountants, (xi) the marketing of the offering by the Company, including, without
            limitation, all costs and expenses of commercial airline tickets, hotels, meals and other travel expenses of officers, employees, agents and other representatives of the Company, (xii) the reasonable, documented out-of-pocket fees,
            disbursements and other charges of the Agents incurred in connection with the offering and (xiii) all fees, costs and expenses for consultants used by the Company in connection with the offering.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Stabilization or Manipulation.</font>&#160; The Company shall not at any time, directly or indirectly (including, without limitation, through the subsidiaries), take any action intended to cause or result in, or
            which might reasonably be expected to cause or result in, or which will constitute, stabilization or manipulation, under the Act or otherwise, of the price of the shares of Common Stock to facilitate the sale or resale of any of the Shares.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Use of Proceeds.</font>&#160; The Company shall apply the net proceeds from the offering and sale of the Shares to be sold by the Company in the manner set forth in the Prospectus under &#8220;Use of Proceeds&#8221; and, except as
            disclosed in the Prospectus, the Company does not intend to use any of the proceeds from the sale of the Shares to repay any outstanding debt owed to the Agents or any affiliate of any Agent.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Clear Market.</font>&#160; The Company shall not offer to sell, sell, pledge, hypothecate, contract or agree to sell, purchase any option to sell, grant any option for the purchase of, lend, or otherwise dispose of,
            directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or warrants or other rights to acquire shares of Common Stock or any other securities of the Company that are
            substantially similar to the Common Stock or permit the registration under the Act of any shares of the Common Stock without the prior written consent of the Agents, unless it gives the Agents at least three business days&#8217; prior written notice
            specifying the nature and date of such proposed transaction.&#160; Notwithstanding the foregoing, the Company may (i) register the offering and sale of the Shares through any Agent pursuant to this Agreement, (ii) issue shares of Common Stock upon
            the exercise of an option or warrant or the conversion of a security outstanding on the date hereof and referred to in the Prospectus, (iii) issue shares of Common Stock or options to purchase Common Stock granted pursuant to existing employee
            benefit plans of the Company or (iv) issue shares of Common Stock pursuant to any non-employee director stock plan, dividend reinvestment plan or stock purchase plan of the Company.&#160; If notice of a proposed transaction is provided by the
            Company pursuant to this subsection (q), either Agent may suspend activity of the transactions contemplated by this Agreement for such period of time as may be requested by the Company or as may be deemed appropriate by such Agent.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Stock Exchange Listing.</font>&#160; The Company shall use its best efforts to cause the Shares to be listed on the Exchange and to maintain such listing.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Additional Notices</font>.&#160; The Company shall notify each Agent immediately after it shall have received notice or obtained knowledge of any information or fact that would alter or affect any opinion, certificate,
            letter or any other document provided to the Agents pursuant to Section 4 below.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Representation Date Certificates</font>.&#160; Upon commencement of the offering of the Shares under this Agreement (and upon the recommencement of the offering of the Shares under this Agreement following the
            termination of a suspension of sales hereunder), and each time that <font style="font-family: 'Times New Roman';">(i)</font> the Registration Statement or the Prospectus is amended or supplemented (other than (x) a prospectus supplement
            relating solely to the offering of securities pursuant to the Registration Statement other than the Shares or (y) an amendment or supplement effected by the filing with the Commission of any document incorporated by reference therein), <font style="font-family: 'Times New Roman';">(ii)</font> there is filed with the Commission an Annual Report on Form 10-K or a Quarterly Report on Form 10-Q, <font style="font-family: 'Times New Roman';">(iii)</font> otherwise as any Agent may
            reasonably request and (<font style="font-family: 'Times New Roman';">iv)</font> Shares are delivered to any Agent pursuant to a Terms Agreement (such commencement date, any such recommencement date, if applicable, and each such date referred
            to in clauses (i), (ii), and (iii) and (iv) above, a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Representation Date</font>&#8221;), to furnish or cause to be furnished to each Agent forthwith a certificate dated and delivered
            as of such date, in form reasonably satisfactory to the Agents, to the effect that the statements contained in the certificate(s) referred to in Section 4(c) are true and correct at the time of such commencement, recommencement, amendment,
            supplement or filing, as the case may be, as though made at and as of such time and modified as necessary to relate to the Registration Statement and the Prospectus as amended and supplemented to the time of delivery of such certificate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Company Counsel Legal Opinions</font>.&#160; On each Representation Date, the Company shall cause to be furnished to the Agents, dated as of such date and addressed to each Agent, in form and substance reasonably
            satisfactory to each Agent, the written opinion of Gibson, Dunn &amp; Crutcher, LLP, outside counsel for the Company, as described in Section 4(d), but modified as necessary to relate to the Registration Statement and the Prospectus, as amended
            and supplemented to the time of delivery of such opinion.&#160; In lieu of delivering such an opinion for dates subsequent to the commencement of the offering of the Shares under this Agreement such counsel may furnish the Agents with a letter (a &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Reliance Letter</font>&#8221;) to the effect that each Agent may rely on a prior opinion delivered under this Section 3(u) to the same extent as if it were dated the date of such letter
            (except that statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of such subsequent date).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Comfort Letters</font>.&#160; On each Representation Date, the Company shall cause the Accountants to deliver to the Agents the comfort letter(s) described in Section 4(f).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Due Diligence</font>.&#160; The Company shall reasonably cooperate with any reasonable due diligence review requested by the Agents or its counsel from time to time in connection with the transactions contemplated
            hereby or any Terms Agreement, including, without limitation, (i) prior to the open of trading on each intended Purchase Date and any Time of Sale or Settlement Date, making available appropriate corporate officers of the Company and, upon
            reasonable request, representatives of the Accountants for an update on diligence matters with representatives of each Agent and its counsel and (ii) at each Representation Date or otherwise as any Agent may reasonably request, providing
            information and making available documents and appropriate corporate officers of the Company and representatives of the Accountants for one or more due diligence sessions with representatives of the Agents and its counsel.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Reservation of the Shares</font>.&#160; The Company shall reserve and keep available at all times, free of preemptive rights, Shares for the purpose of enabling the Company to satisfy its obligations hereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Agent Trading</font>.&#160; The Company hereby consents to the Agents trading in the Common Stock for each Agent&#8217;s own account and for the account of its clients at the same time as sales of the Shares pursuant to this
            Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Deemed Representations and Warranties</font>.&#160; The Company hereby agrees that each acceptance by it of an offer to purchase Shares hereunder shall be deemed to be (i) an affirmation to the Agents that the
            representations and warranties of the Company contained in or made pursuant to this Agreement are true and correct as of the date of such acceptance as though made at and as of such date and (ii) an undertaking that such representations and
            warranties will be true and correct as of the Time of Sale and the Settlement Date for the Shares relating to such acceptance as though made at and as of each of such dates (except that such representations and warranties shall be deemed to
            relate to the Registration Statement and the Prospectus as amended and supplemented to the date of such acceptance, such Time of Sale or such Settlement Date, as the case may be).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Board Authorization</font>.&#160; Prior to delivering notice of the proposed terms of an Agency Transaction or a Principal Transaction pursuant to Section 1 (or at such time as otherwise agreed between the Company and
            the Agents), the Company shall, if applicable, have (i) obtained from its board of directors or a duly authorized subcommittee thereof all necessary corporate authority for the sale of the Shares pursuant to the relevant Agency Transaction or
            Principal Transaction, as the case may be, and (ii) provided to each Agent a copy of the relevant board resolutions or other authority.&#160; In lieu of delivering such resolutions for dates subsequent to the commencement of the offering of the
            Shares under this Agreement, the Company may deliver an officer&#8217;s certificate indicating that any such previously-delivered board resolutions or authority remain in full force and effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Offer to Refuse to Purchase</font>.&#160; If to the knowledge of the Company any condition set forth in Section 4(a) of this Agreement shall not have been satisfied on the applicable Settlement Date, the Company shall
            offer to any person who has agreed to purchase Shares from the Company as the result of an offer to purchase solicited by an Agent the right to refuse to purchase and pay for such Shares.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Exchange Act Reports</font>.&#160; The Company shall, subject to subsection (a) of this Section 3, (i) timely file all reports and any definitive proxy or information statements required to be filed by the Commission
            pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for the duration of the Prospectus Delivery Period and (ii) disclose in its quarterly reports on Form 10-Q and in its annual report
            on Form 10-K a summary detailing, for the relevant reporting period, the number of Shares sold through or to the Agents under this Agreement, the net proceeds received by the Company from such sales and the compensation paid by the Company to
            the Agents with respect to such sales.&#160; In lieu of compliance with the requirement set forth in clause (ii) of the immediately preceding sentence, the Company may prepare a prospectus supplement with such summary information and, at least once
            a quarter and subject to subsection (a) of this Section 3, file such prospectus supplement pursuant to Rule 424(b) under the Act (and within the time periods required by Rule 424(b) and Rule 430A, 430B or 430C under the Act).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Recognition of the U.S. Special Resolution Regimes</font>.&#160; In the event that an Agent is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Agent
            of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime (defined below) if this Agreement, and any such
            interest and obligation, were governed by the laws of the United States or a state of the United States.&#160; In the event that any Agent that is a Covered Entity or a BHC Act Affiliate of an Agent becomes subject to a proceeding under a U.S.
            Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if
            this Agreement were governed by the laws of the United States or a state of the United States.&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">BHC Act Affiliate</font>&#8221; shall mean &#8220;affiliate&#8221; as defined in, and shall be
            interpreted in accordance with, 12 U.S.C. &#167; 1841(k).&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Covered Entity</font>&#8221; shall mean any of the following: (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted
            in accordance with, 12 C.F.R. &#167; 252.82(b), (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b) or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12
            C.F.R. &#167; 382.2(b).&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Default Right</font>&#8221; shall mean default right as defined and interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable.&#160; &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">U.S. Special Resolution Regime</font>&#8221; shall mean each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall
            Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Conditions of the Obligations of the Agents</u></font>.&#160; The obligations of each Agent hereunder are subject to (i) the accuracy of the representations and warranties of the Company on the date hereof, on each Representation Date
            and as of each Time of Sale and Settlement Date, (ii) the performance of the Company of its obligations hereunder and (iii) the following additional conditions:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Stop Orders, Requests for Information.</font>&#160; (i) No stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall be pending or are, to
            the knowledge of the Company, threatened by the Commission, and the Company shall not have received from the Commission any notice pursuant to Rule 401(g)(2) of the Act objecting to use of the automatic shelf registration statement form (ii) no
            order suspending the qualification or registration of the Shares under the securities or Blue Sky laws of any jurisdiction shall be in effect and no proceeding for such purpose shall be pending before or threatened or contemplated by the
            authorities of any such jurisdiction and (iii) any request for additional information on the part of the staff of the Commission or any such authorities shall have been complied with to the satisfaction of the staff of the Commission or such
            authorities and (iv) after the date hereof no amendment or supplement to the Registration Statement or the Prospectus (other than (x) a prospectus supplement relating solely to the offering of securities pursuant to the Registration Statement
            other than the Shares or (y) an amendment or supplement effected by the filing with the Commission of any document incorporated by reference therein) shall have been filed unless a copy thereof was first submitted to the Agents and each Agent
            did not reasonably object thereto within a reasonable time.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">No Material Adverse Changes.</font>&#160; Since the date of the most recent financial statements of the Company included or incorporated by reference in the Registration Statement and the Prospectus, except as
            described in the Registration Statement and the Prospectus, there shall not have been a Material Adverse Change.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Officer&#8217;s Certificates.</font>&#160; The Agents shall have received, on each Representation Date, one or more accurate certificates, dated such date and signed by an executive officer of the Company, in form and
            substance reasonably satisfactory to each Agent, to the effect set forth in clauses (a) and (b) above and to the effect that:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">each signer of such certificate has
            carefully examined the Registration Statement, the Prospectus (including any documents filed under the Exchange Act and deemed to be incorporated by reference into the Prospectus) and each Permitted Free Writing Prospectus, if any;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">as of such date and as of each Time of
            Sale subsequent to the immediately preceding Representation Date, if any, neither the Registration Statement, the Prospectus nor any Permitted Free Writing Prospectus contained any untrue statement of a material fact or omitted to state any
            material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">each of the representations and
            warranties of the Company contained in this Agreement are, as of such date and each Time of Sale subsequent to the immediately preceding Representation Date, if any, true and correct; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">each of the covenants and agreements
            required herein to be performed by the Company on or prior to such date has been duly, timely and fully performed and each condition herein required to be complied with by the Company on or prior to such date has been duly, timely and fully
            complied with.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Opinions of Counsel to the Company.</font>&#160; The Agents shall have received, on each Representation Date, an opinion and negative assurance letter of Gibson, Dunn &amp; Crutcher, LLP, outside counsel for the
            Company, each dated such date and addressed to each Agent, in form and substance satisfactory to each Agent.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Opinion of Counsel to the Agents.</font>&#160; The Agent shall have received, on each Representation Date, a negative assurance letter of Dorsey &amp; Whitney LLP, outside counsel for the Agents, dated such date and
            addressed to each Agent, in form and substance reasonably satisfactory to each Agent.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Accountants&#8217; Comfort Letter.</font>&#160; The Agents shall have received, on each Representation Date, letters dated such date and addressed to each Agent, in form and substance reasonably satisfactory to each Agent,
            (i) confirming that the Accountants are an independent registered public accounting firm within the meaning of the Act, the Exchange Act and the PCAOB, (ii) stating, as of such date, the conclusions and information of the type ordinarily
            included in accountants&#8217; &#8220;comfort letters&#8221; to sales agents in connection with registered &#8220;at the market&#8221; offerings with respect to the audited and unaudited financial statements and certain other financial information contained or incorporated
            by reference in the Registration Statement and the Prospectus (the first such letter, the &#8220;Initial Comfort Letter&#8221;) and (iii) in the case of any such letter after the Initial Comfort Letter, updating the Initial Comfort Letter with any
            information that would have ordinarily been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, as
            amended or supplemented to the date of such letter.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Due Diligence</font>.&#160; The Company shall have complied with all of its due diligence obligations required pursuant to Section 3(w).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Compliance with Blue Sky Laws.</font>&#160; The Shares shall be qualified for sale in such states and jurisdictions as the Agents may reasonably request, and each such qualification shall be in effect and not subject
            to any stop order or other proceeding on the relevant Representation Date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Stock Exchange Listing.</font>&#160; The Shares shall have been duly authorized for listing or quotation on the Exchange, subject only to notice of issuance at or prior to the applicable Settlement Date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Regulation M</font>.&#160; The Common Stock shall be an &#8220;actively-traded security&#8221; excepted from the requirements of Rule 101 of Regulation M under the Exchange Act by subsection (c)(1) of such rule.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Indemnification of the Agents.</font>&#160; The Company shall indemnify and hold harmless each Agent, the directors, officers, employees, counsel, affiliates and agents of each Agent and each person, if any, who
            controls each Agent within the meaning of Section 15 of the Act or Section 20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses and damages (including, without limitation, any and all investigative, legal
            and other expenses reasonably incurred in connection with any claim asserted), to which they, or any of them, may become subject under the Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise,
            insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including
            any information deemed to be a part thereof pursuant to Rules 430A, 430B or 430C, as applicable, including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material fact required to be stated
            therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Permitted Free Writing Prospectus or the Prospectus (or any amendment or supplement
            thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iii) any untrue statement or alleged
            untrue statement of a material fact contained in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Shares, including any roadshow or investor
            presentations made to investors by the Company (whether in person or electronically) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under
            which they were made, not misleading; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that the Company shall not be liable to
            the extent that such loss, claim, liability, expense or damage arises from the sale of the Shares in the public offering to any person by each Agent and is based on an untrue statement or omission or alleged untrue statement or omission made in
            reliance on and in conformity with information relating to each Agent furnished in writing to the Company by such Agent expressly for inclusion in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, which
            constitutes the information set forth in <font style="font-family: 'Times New Roman'; font-weight: bold;"><u>Schedule 2</u></font> hereto.&#160; This indemnity agreement will be in addition to any liability that the Company might otherwise have.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Indemnification of the Company.</font>&#160; An Agent shall indemnify and hold harmless the Company, the directors, officers, employees, counsel and agents and each person, if any, who controls the Company within the
            meaning of Section 15 of the Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Agent, but only insofar as losses, claims, liabilities, expenses or damages arise out of or are based on
            any untrue statement or omission or alleged untrue statement or omission made in reliance on and in conformity with information relating to such Agent furnished in writing to the Company by such Agent expressly for inclusion in the Registration
            Statement, any Permitted Free Writing Prospectus or the Prospectus.&#160; This indemnity will be in addition to any liability that such Agent might otherwise have.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Indemnification Procedures.</font>&#160; Any party that proposes to assert the right to be indemnified under this Section 5 shall, promptly after receipt of notice of commencement of any action against such party in
            respect of which a claim is to be made against an indemnifying party or parties under this Section 5, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify
            such indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party under the foregoing provisions of this Section 5 unless, and only to the extent that, such omission results in the
            forfeiture of substantive rights or defenses by the indemnifying party.&#160; If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be entitled to
            participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying party
            similarly notified, to assume the defense of the action, with counsel satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the indemnifying party
            will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense.&#160; The
            indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (i) the employment of counsel by the
            indemnified party has been authorized in writing by the indemnifying party, (ii) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are
            different from or in addition to those available to the indemnifying party, (iii) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which
            case the indemnifying party shall not have the right to direct the defense of such action on behalf of the indemnified party) or (iv) the indemnifying party has not in fact employed counsel to assume the defense of such action within a
            reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel shall be at the expense of the indemnifying party or parties.&#160; It is understood
            that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to
            practice in such jurisdiction at any one time for all such indemnified party or parties; provided that, for the purposes hereof, each state, province or similar political subdivision within a country will be considered a separate jurisdiction.&#160;
            All such fees, disbursements and other charges shall be reimbursed by the indemnifying party promptly as they are incurred.&#160; An indemnifying party shall not be liable for any settlement of any action or claim effected without its written
            consent (which consent will not be unreasonably withheld or delayed).&#160; No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or
            threatened claim, action or proceeding relating to the matters contemplated by this Section 5 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each
            indemnified party from all liability arising or that may arise out of such claim, action or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified
            party.&#160; Notwithstanding the foregoing, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by this Section 5(c), the indemnifying
            party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such
            indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with
            such request prior to the date of such settlement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Contribution.</font>&#160; In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing paragraphs of this Section 5 is applicable in accordance
            with its terms but for any reason is held to be unavailable from the Company or an Agent, the Company and such Agent shall contribute to the total losses, claims, liabilities, expenses and damages (including, without limitation, any
            investigative, legal and other expenses reasonably incurred in connection with and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution received by the Company from persons
            other than such Agent, such as persons who control the Company within the meaning of the Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for contribution) to which the
            Company and such Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and an Agent on the other hand.&#160; The relative benefits received by the Company on the one
            hand and an Agent on the other hand shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the sum of (i) the total compensation to such Agent
            pursuant to Section 1(a)(vii) (in the case of one or more Agency Transactions hereunder) and (ii) the underwriting discounts and commissions received by such Agent as set forth in the table on the cover page of the Prospectus (in the case of
            one or more Principal Transactions pursuant to Terms Agreements).&#160; If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is
            appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and such Agent, on the other hand, with respect to the statements or omissions which
            resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering.&#160; Such relative fault shall be determined by reference to whether the
            untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or an Agent, the intent of the parties and their relative knowledge, access to
            information and opportunity to correct or prevent such statement or omission.&#160; The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action in respect thereof, referred to above in
            this subsection (d) shall be deemed to include, for purpose of this subsection (d), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.&#160;
            Notwithstanding the provisions of this subsection (d), no Agent shall be required to contribute any amount in excess of the sum of (i) the total compensation to such Agent pursuant to Section 1(a)(vii) (in the case of one or more Agency
            Transactions hereunder) and (ii) the underwriting discounts and commissions received by such Agent as set forth in the table on the cover page of the Prospectus (in the case of one or more Principal Transactions pursuant to Terms Agreements),
            and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&#160; For purposes of this
            subsection (d), any person who controls a party to this Agreement within the meaning of the Act will have the same rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the same
            rights to contribution as the Company, subject in each case to the provisions hereof.&#160; Any party entitled to contribution, promptly after receipt of notice of commencement of any action against such party in respect of which a claim for
            contribution may be made under this subsection (d), will notify any such party from whom contribution may be sought, but the omission so to notify will not relieve the party from whom contribution may be sought from any other obligation it may
            have under this subsection (d).&#160; No party will be liable for contribution with respect to any action or claim settled without its written consent (which consent will not be unreasonably withheld).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Survival.</font>&#160; The obligations of the Company under this Section 5 shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to any
            affiliate of an Agent and each person, if any, who controls such Agent or any such affiliate within the meaning of the Act; and the obligations of each Agent under this Section 5 shall be in addition to any liability which it may otherwise have
            and shall extend, upon the same terms and conditions, to each officer and director of the Company and to each person, if any, who controls the Company within the meaning of the Act. The indemnity and contribution agreements contained in this
            Section 5 and the representations and warranties of the Company and each Agent contained in this Agreement shall remain operative and in full force and effect regardless of (i) any investigation made by or on behalf of the Company or an Agent,
            (ii) acceptance of any of the Shares and payment therefor or (iii) any termination of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Company may terminate this Agreement
            in its sole discretion at any time upon giving prior written notice to the Agents. Any such termination shall be without liability of any party to the other party, except that (i) with respect to any pending sale, the obligations of the
            Company, including, without limitation, in respect of compensation of the Agents, shall remain in full force and effect notwithstanding such termination; and (ii) the provisions of Sections 2, 3(n), 5, 7(c), 7(e) and 7(h) of this Agreement
            shall remain in full force and effect notwithstanding such termination.&#160; In the case of any sale by the Company pursuant to a Terms Agreement, the obligations of the Company pursuant to such Terms Agreement (including the terms of this
            Agreement incorporated by reference therein) may not be terminated by the Company without the prior written consent of the Agents.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Any Agent may terminate this Agreement
            as to itself in its sole discretion at any time upon giving prior written notice to the Company and the other Agent.&#160; Any such termination shall be without liability of any party to the other party, except that (i) with respect to any pending
            sale, the obligations of the Company, including, without limitation, in respect of compensation of the terminating Agent, shall remain in full force and effect notwithstanding such termination; and (ii) the provisions of Sections 2, 3(n), 5,
            7(c), 7(e) and 7(h) of this Agreement shall remain in full force and effect notwithstanding such termination.&#160; In the case of any purchase by an Agent pursuant to a Terms Agreement, such Agent may, by written notice to the Company, terminate
            its obligations pursuant to such Terms Agreement at any time prior to or on the Settlement Date if, since the time of execution of the Terms Agreement or the respective dates as of which information is given in the Registration Statement and
            the Prospectus:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">trading of the Common Stock shall have
            been suspended on the Exchange;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">trading generally shall have been
            suspended or limited on or by, as the case may be, any &#8220;national securities exchange&#8221; (as defined in the Exchange Act), or minimum or maximum prices shall have been generally established on any such exchange, or additional material governmental
            restrictions, not in force on the date of this Agreement, shall have been imposed upon trading in securities generally by any such exchange or by order of the Commission or any court or other governmental authority;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">a general banking moratorium shall
            have been declared by federal or New York authorities or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United States;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">the United States shall have become
            engaged in new hostilities, there shall have been an escalation in hostilities involving the United States or there shall have been a declaration of a national emergency or war by the United States or there shall have occurred such a material
            adverse change in general economic, political or financial conditions, including, without limitation, as a result of terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United
            States shall be such), or any other national calamity or crisis shall have occurred, the effect of any of which is such as to make it impracticable or inadvisable to market the Shares on the terms and in the manner contemplated by the
            Prospectus; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">if the Company or any of the
            subsidiaries shall have sustained a loss material or substantial to the Company or any of the subsidiaries by reason of flood, fire, accident, hurricane, earthquake, theft, sabotage, or other calamity or malicious act, whether or not such loss
            shall have been insured, the effect of any of which is such as to make it impracticable or inadvisable to market the Shares on the terms and in the manner contemplated by the Prospectus; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">if there shall have been a Material
            Adverse Change.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">This Agreement shall remain in full
            force and effect until the earliest to occur of (A) termination of this Agreement pursuant to subsection (a) or (b) above or otherwise by mutual written agreement of the parties, and (B) such date that the aggregate gross sales proceeds of the
            Shares sold pursuant to this Agreement (including, without limitation, one or more Terms Agreements pursuant hereto) equals the Maximum Amount, in each case except that (i) with respect to any pending sale, the obligations of the Company,
            including, without limitation, in respect of compensation of an Agent, shall remain in full force and effect notwithstanding such termination; and (ii) the provisions of Sections 2, 3(n), 5, 7(c), 7(e) and 7(h) of this Agreement shall remain in
            full force and effect notwithstanding such termination.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Any termination of this Agreement shall
            be effective on the date specified in the notice of termination; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that such termination shall not be effective until the close of business on the date of receipt
            of such notice by the Agents or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall settle in accordance with the provisions of Section 1 (in the case of an
            Agency Transaction) or in accordance with the relevant Terms Agreement (in the case of a Principal Transaction).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Miscellaneous</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Notices.</font>&#160; Notice given pursuant to any of the provisions of this Agreement shall be in writing and, unless otherwise specified, shall be mailed, hand delivered or telecopied (i) if to the Company, at the
            office of the Company, 200 South Wacker Drive, Suite 2100, Chicago, Illinois 60606 (FAX: (312) 489-5899), Attention: General Counsel, or (ii) <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">if to (A)</font> BMO, at the
            offices of BMO Capital Markets Corp., 151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Street, New York, New York 10036, Attention: Equity Capital Markets desk, with a copy to the Legal Department (Fax: (212) 702-1205) and (B) <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">RBC, at the offices of RBC Capital Markets, LLC, Attention: Equity Syndicate, 200 Vesey Street, 8th Floor, Brookfield Place, New York, New York, NY 10281, Attention: Andrew Jones (email: Andrew.jones@rbccm.com)</font>.&#160;





            Any such notice shall be effective only upon receipt.&#160; Any notice under Section 5 may be made by telecopy or telephone, but if so made shall be subsequently confirmed in writing (which may include, in the case of the Agents, electronic mail to
            any Authorized Company Representative).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">[Intentionally Omitted]</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Survival of Representations and Warranties.</font>&#160; All representations, warranties and agreements of the Company and the Agents contained herein or in certificates or other instruments delivered pursuant hereto
            (including, without limitation, any Terms Agreement) shall remain operative and in full force and effect, as of their respective dates, regardless of any investigation made by or on behalf of the Company or the Agents or any of their
            controlling persons and shall survive delivery of and payment for the Shares hereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Disclaimer of Fiduciary Relationship</font>.&#160; The Company acknowledges and agrees that (i) the purchase and sale of the Shares pursuant to this Agreement, including the determination of the terms of the offering
            and any related discounts and commissions, is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and each Agent, on the other hand, (ii) in connection with the offering contemplated by this Agreement and the process
            leading to such transaction, each Agent owes no fiduciary duties to the Company or its securityholders, creditors, employees or any other party, (iii) no Agent has assumed nor will it assume any advisory or fiduciary responsibility in favor of
            the Company with respect to the offering of the Shares contemplated by this Agreement or the process leading thereto (irrespective of whether an Agent or its affiliates has advised or is currently advising the Company on other matters) and no
            Agent has any obligation to the Company with respect to the offering of the Shares contemplated by this Agreement except the obligations expressly set forth in this Agreement, (iv) an Agent and its affiliates may be engaged in a broad range of
            transactions that involve interests that differ from those of the Company and (v) no Agent has provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated by this Agreement and the Company has consulted
            its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Governing Law.</font>&#160; THIS AGREEMENT AND EACH TERMS AGREEMENT, AND ANY DISPUTE, CLAIM OR CONTROVERSY ARISING UNDER OR RELATED TO THIS AGREEMENT OR SUCH TERMS AGREEMENT, SHALL BE GOVERNED BY AND CONSTRUED IN
            ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE.&#160; Each party hereto hereby irrevocably submits for purposes of any action arising from this Agreement or any Terms
            Agreement brought by the other party hereto to the jurisdiction of the courts of New York State located in the Borough of Manhattan and the U.S. District Court for the Southern District of New York.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Counterparts</font>.&#160; This Agreement and each Terms Agreement may be signed in two or more counterparts with the same effect as if the signatures thereto and hereto were upon the same instrument. Counterparts may
            be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
            www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Survival of Provisions Upon Invalidity of Any Single Provision.</font>&#160;&#160; In case any provision in this Agreement or any Terms Agreement shall be invalid, illegal or unenforceable, the validity, legality and
            enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Waiver of Jury Trial.</font>&#160; Each of the Company and each Agent hereby irrevocably waives any right it may have to a trial by jury in respect of any claim based upon or arising out of this Agreement, any Terms
            Agreement or the transactions contemplated hereby or thereby.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Titles and Subtitles.</font>&#160; The titles of the sections and subsections of this Agreement and any Terms Agreement are for convenience and reference only and are not to be considered in construing this Agreement
            or such Terms Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">Entire Agreement.</font>&#160; Other than the terms set forth in each Agency Transaction Notice delivered hereunder and each Terms Agreement executed and delivered pursuant hereto, this Agreement embodies the entire
            agreement and understanding between the parties hereto and supersedes all prior agreements and understandings relating to the subject matter hereof.&#160; Neither this Agreement nor any Terms Agreement may be amended or otherwise modified or any
            provision hereof waived except by an instrument in writing signed by the Agents and the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature page follows</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Please confirm that the foregoing correctly sets forth the agreement between the Company and each Agent.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc8fe76d1a32f40d5916b522b1e3c948e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" id="z95668820406541279e7d9e027e2b9b2c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td colspan="3" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">COEUR MINING, INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 3%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
              </td>
              <td style="vertical-align: top; font-size: 10pt;" colspan="2">
                <div style="text-align: left; font-family: 'Times New Roman';"><u><font style="font-family: 'Times New Roman';">/s/ Mitchell J. Krebs</font></u></div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
              </td>
              <td style="width: 42%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Mitchell J. Krebs</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
              </td>
              <td style="width: 42%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">President and Chief Executive Officer</div>
              </td>
            </tr>

        </table>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accepted and agreed as of</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the date first above written:</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
          <table cellspacing="0" cellpadding="0" border="0" id="zc8cf66df6add45969fd5dbe5e84ee0e4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="vertical-align: top;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BMO CAPITAL MARKETS CORP.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
                </td>
                <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Brad Pavelka</td>
                <td style="width: 62%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;" rowspan="1">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                  </div>
                </td>
                <td style="vertical-align: top;" rowspan="1" colspan="2">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Name: Brad Pavelka</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;" rowspan="1">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><br>
                  </div>
                </td>
                <td style="vertical-align: top;" rowspan="1" colspan="2">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Title: Managing Director</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" id="z16cb76e566f9437fb4aafcf23e851ae5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="vertical-align: top;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RBC CAPITAL MARKETS, LLC</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
                </td>
                <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"> /s/ Michael Ventura </td>
                <td style="width: 62%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td style="vertical-align: top;" rowspan="1" colspan="2">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Name: Michael Ventura</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td style="vertical-align: top;" rowspan="1" colspan="2">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Title: Managing Director</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE 1</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">AUTHORIZED COMPANY REPRESENTATIVES</div>
      <div style="font-size: 10pt;">&#160; <br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z37a038f643a94bbe99c292d94bd6e3f6" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 27pt;">
                <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Thomas S. Whelan, Senior Vice President and Chief Financial Officer</font></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zcf213e4fc05a42b3a485e042a07ca626" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="vertical-align: top; width: 27pt;">
                <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font></div>
              </td>
              <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';">Anne Beckelheimer, Vice President, Tax and Treasurer</font></font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE 2</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">INFORMATION SUPPLIED BY AGENTS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Each Agent&#8217;s name and the statement that such Agent will not engage in any transactions that stabilize the price of the Common Stock appearing in the last sentence of the
        first paragraph under the caption &#8220;Plan of Distribution&#8221; in the Prospectus Supplement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE 3</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">ISSUER FREE WRITING PROSPECTUSES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">None.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">SCHEDULE 2(cc)</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Technical Reports</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z0fba8817345e4279a4acb1503c1cac1d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 70.2%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Mine</div>
            </td>
            <td style="width: 29.8%; vertical-align: middle; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Technical Report</div>
              <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Filing Date</div>
            </td>
          </tr>
          <tr>
            <td style="width: 70.2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Palmarejo Operations, Mexico, Technical Report Summary, effective December 31, 2021</div>
            </td>
            <td style="width: 29.8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; font-family: 'Times New Roman';">February 16, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 70.2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rochester Operations, Nevada, Technical Report Summary, effective December 31, 2021</div>
            </td>
            <td style="width: 29.8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman';">February 16, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 70.2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Kensington Gold Operations, Alaska, Technical Report Summary, effective December 31, 2021</div>
            </td>
            <td style="width: 29.8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; font-family: 'Times New Roman';">February 16, 2022</div>
            </td>
          </tr>
          <tr>
            <td style="width: 70.2%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Wharf Operations, South Dakota, Technical Report Summary, effective December 31, 2021</div>
            </td>
            <td style="width: 29.8%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman';">February 16, 2022</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">EXHIBIT A</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Coeur Mining, Inc. Letterhead]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">[_______], 20[__]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BMO Capital Markets Corp.</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Street</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, NY 10036</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RBC Capital Markets, LLC</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">200 Vesey Street, 8th Floor</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Brookfield Place New York</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10281</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">VIA EMAIL</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>AGENCY TRANSACTION NOTICE</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The purpose of this Agency Transaction Notice is to propose certain terms of the Agency Transaction entered into with [BMO Capital Markets Corp.][RBC
        Capital Markets, LLC] under, and pursuant to, that certain ATM Equity Offering Sales Agreement between the Company and BMO Capital Markets Corp. and RBC Capital Markets, LLC, dated February 23, 2023 (the &#8220;Agreement&#8221;).&#160; Please indicate your
        acceptance of the proposed terms below.&#160; Upon acceptance, the particular Agency Transaction to which this Agency Transaction Notice relates shall supplement, form a part of, and be subject to, the Agreement.&#160; Capitalized terms used but not
        otherwise defined herein shall have the meanings ascribed to them in the Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The terms of the particular Agency Transaction to which this Agency Transaction Notice relates are as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="width: 90%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;" id="z2b3d80867e874a48a04dbdd4c3132998">

            <tr>
              <td style="width: 45%;">Trading Day(s) on which Shares may be Sold:</td>
              <td style="width: 45%;">
                <div style="font-family: 'Times New Roman';">[_______], 20[__], [_______], 20[__] . . . [_______], 20[__]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;"><br>
              </td>
              <td style="width: 45%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Maximum Number of Shares to be Sold in the Aggregate:</div>
              </td>
              <td style="width: 45%;">[_______]</td>
            </tr>
            <tr>
              <td style="width: 45%;"><br>
              </td>
              <td style="width: 45%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Maximum Number of Shares to be Sold on each Trading Day:</div>
              </td>
              <td style="width: 45%;">
                <div style="font-family: 'Times New Roman';">[_______]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;"><br>
              </td>
              <td style="width: 45%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 45%;">Floor Price:</td>
              <td style="width: 45%;">
                <div style="font-family: 'Times New Roman';">USD[__.__]</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Remainder of Page Intentionally Blank</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Very truly yours,</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td colspan="2" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">COEUR MINING, INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="vertical-align: top; width: 45%; font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
              </td>
              <td style="vertical-align: top; border-bottom: 2px solid black; width: 45%; font-size: 10pt;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
              </td>
              <td style="width: 45%; vertical-align: top; font-size: 10pt;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
              <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
              </td>
              <td style="width: 45%; vertical-align: top; font-size: 10pt;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accepted and agreed as of<font style="font-family: 'Times New Roman';"><br>
          </font>the date first above written:</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" id="z99ab11f906bc4d6eb5884e62d56d5fde" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[BMO CAPITAL MARKETS CORP.]</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[RBC CAPITAL MARKETS, LLC]</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
              </tr>
              <tr>
                <td style="width: 3%; vertical-align: middle; padding-bottom: 2px;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
                </td>
                <td style="width: 35%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td style="width: 62%; vertical-align: middle; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
                </td>
              </tr>
              <tr>
                <td style="vertical-align: middle;" colspan="3">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Title:</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">EXHIBIT B</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">COEUR MINING, INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Common Stock</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">TERMS AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">[_______], 20[__]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">BMO Capital Markets Corp.</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Street</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, NY 10036</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">RBC Capital Markets, LLC</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">200 Vesey Street, 8th Floor</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Brookfield Place New York</div>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10281</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Coeur Mining, Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes, subject to the terms and conditions stated herein, in Schedule hereto and in the
        ATM Equity Offering Sales Agreement, dated February 23, 2023 (the &#8220;Sales Agreement&#8221;), between the Company and BMO Capital Markets Corp. (&#8220;BMO&#8221;) and RBC Capital Markets, LLC (&#8220;RBC&#8221;), to issue and sell to [BMO][RBC] [_______] shares of the Company&#8217;s
        common stock, par value $[_.__] per share (the &#8220;Purchased Shares&#8221;)[, and, solely for the purpose of covering over-allotments, to grant to [BMO][RBC] the option to purchase an additional [_______] shares of such common stock (the &#8220;Additional
        Shares&#8221;)]. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[BMO][RBC] shall have the right to purchase from the Company all or a portion of the Additional Shares as may be necessary to cover over-allotments
        made in connection with the offering of the Purchased Shares at the same purchase price per share to be paid by [BMO][RBC] to the Company for the Purchased Shares.&#160; This option may be exercised by [BMO][RBC] at any time (but not more than once) on
        or before the thirtieth day following the date of this Terms Agreement, by written notice to the Company.&#160; Such notice shall set forth the aggregate number of Additional Shares as to which the option is being exercised, and the date and time when
        the Additional Shares are to be delivered (such date, the &#8220;Option Settlement Date&#8221;); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>,
        that the Option Settlement Date shall not be earlier than the Settlement Date (as set forth in the Schedule hereto) nor earlier than the second business day after the date on which the option shall have been exercised nor later than the fifth
        business day after the date on which the option shall have been exercised.&#160; Payment of the purchase price for the Additional Shares shall be made at the Option Settlement Date in the same manner and at the same office as the payment for the
        Purchased Shares.]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each of the provisions of the Sales Agreement not specifically related to the solicitation by [BMO][RBC], as agent of the Company, of offers to
        purchase Shares in Agency Transactions is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">An amendment to the Registration Statement, or a supplement to the Prospectus, as the case may be, relating to the Purchased Shares [and the Additional
        Shares], in the form heretofore delivered to [BMO][RBC] is now proposed to be filed with the Securities and Exchange Commission.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms and conditions set forth herein and in the Schedule hereto and subject the terms and conditions of the Sales Agreement
        incorporated herein as provided in the second immediately preceding paragraph, the Company agrees to issue and sell to [BMO][RBC], and [BMO][RBC] agrees to purchase from the Company, the Purchased Shares at the time and place and at the purchase
        price set forth in the Schedule hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Remainder of Page Intentionally Blank</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">If the foregoing is in accordance with your understanding, please sign and return to us a counterpart hereof, whereupon this Terms Agreement, including
        those provisions of the Sales Agreement incorporated herein by reference, shall constitute a binding agreement between [BMO][RBC] and the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; text-align: left;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

              <tr>
                <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="vertical-align: top; font-size: 10pt;" rowspan="1" colspan="2">
                  <div style="text-align: left; font-family: 'Times New Roman';">COEUR MINING, INC.</div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="vertical-align: top; width: 47%; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="width: 3%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
                </td>
                <td style="vertical-align: top; border-bottom: 2px solid black; width: 47%; font-size: 10pt;"><br>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="width: 3%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';"><br>
                  </div>
                </td>
                <td style="width: 47%; vertical-align: top; font-size: 10pt;">
                  <div style="margin-left: 9pt">Name: </div>
                </td>
              </tr>
              <tr>
                <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td style="width: 3%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';"><br>
                  </div>
                </td>
                <td style="width: 47%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman'; margin-left: 9pt;">Title:</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <font style="font-size: 10pt;"><br>
      </font>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Accepted and agreed as of</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">the date first above written:</div>
      <div style="font-size: 10pt; text-align: left;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc3e2fe9f81294b9cb0845f06d6736a3c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: middle;" colspan="3">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[BMO CAPITAL MARKETS CORP.]</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle;" colspan="3">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle;" colspan="3">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[RBC CAPITAL MARKETS, LLC]</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: middle;" colspan="3">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle; padding-bottom: 2px;">
              <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 35%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 62%; vertical-align: middle; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Name:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: middle;">&#160;</td>
            <td style="vertical-align: middle;" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Title:</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Schedule to Terms Agreement</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">[Price to Public:</div>
      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">USD[__.__] per share]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchase Price by [BMO][RBC]:</div>
      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">USD[__.__] per share</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Method of and Specified Funds for Payment of Purchase Price:</div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[By wire transfer to a bank account specified by the Company in same day funds.]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Method of Delivery:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">To [BMO&#8217;s][RBC&#8217;s] account, or the account of [BMO&#8217;s][RBC&#8217;s] designee, at The Depository Trust Company via DWAC in return for payment of the purchase
        price.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Settlement Date:</div>
      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[_______], 20[__]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Closing Location:</div>
      <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">[_______]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Documents to be Delivered:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following documents referred to in the Sales Agreement shall be delivered as a condition to the closing (which documents shall be dated on or as of the date of the
        Terms Agreement to which this Scheduled is annexed):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z60c0c63288a744adac4b241c66e1fef0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the officer&#8217;s certificate referred to in Section 4(c);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z20be3013989a4920892a3f57c089cced" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the legal opinions referred to in Section 4(d) and (e);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6a66b377ff1441ca98ab0e3f4bec84ba" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the &#8220;comfort letter&#8221; referred to in Section 4(f); and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z40f246aaaa614344bd386049dc2852ca" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">such other documents as [BMO][RBC] shall reasonably request.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">[Indemnity:</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">[_______]]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">[Lockup:</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In addition to, and without limiting the generality of, the covenant set forth in Section 3(q) of the Sales Agreement, [________].]</div>
      <div style="text-align: left; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>brhc10048619_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Summit
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="width: 100%;" class="BRPFPageHeader"></div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit 5.1</font><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font> </div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: left;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z8ca23c2550644edd98a1b11b831c760f">

          <tr>
            <td style="width: 50.00%;" colspan="1">
              <div>
                <div>
                  <div>
                    <div>
                      <div>
                        <div>
                          <div>
                            <div>
                              <div>
                                <div>
                                  <div>
                                    <div>
                                      <div><img src="image01.jpg">
                                        <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
                                          </font> </div>
                                        <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
                                          </font> </div>
                                        <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
                                          </font> </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </td>
            <td style="width: 50.00%;" colspan="1">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#160;<img src="image02.jpg"></div>
            </td>
          </tr>

      </table>
    </div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div style="text-align: right; font-family: 'Times New Roman'; font-size: 8pt;"> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
    </font> </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Client: 19398-00083</div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
  <div style="text-align: left;">
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">February 23, 2023</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">Coeur Mining, Inc.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">104 S. Michigan Ave., Suite 900</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">Chicago, IL 60603</div>
    <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font> </div>
    <table cellspacing="0" cellpadding="0" id="zb4899e8953954d48b6f1f1332936baa7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">

        <tr>
          <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Re:</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman'; font-size: 10pt;">Coeur Mining, Inc.</div>
          </td>
        </tr>

    </table>
    <div style="text-indent: -36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Common Stock Offering</div>
    <div style="margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Registration Statement on Form S-3 (File No. 333-262799)</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">We have examined the Registration Statement on Form S-3, File No. 333-262799 (the &#8220;<u>Registration Statement</u>&#8221;), of Coeur Mining, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;),
      filed with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) pursuant to the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;), and the prospectus and prospectus supplement with respect thereto, dated February 17, 2022
      and February 23, 2023, respectively, in connection with the offering by the Company from time to time pursuant to Rule 415 under the Securities Act of shares of the Company&#8217;s common stock, par value $0.01 per share, having an aggregate offering price
      to the public of up to $100,000,000 (the &#8220;<u>Shares</u>&#8221;). The Shares will be issued pursuant to that certain ATM Equity Offering&#160; Sales Agreement dated as of February 23, 2023 (the &#8220;<u>Sales Agreement</u>&#8221;) among the Company and the sales agents
      named therein.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">In arriving at the opinion expressed below, we have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies
      of the originals, of such documents, records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary or advisable to enable us to render this opinion. In our examination, we have assumed
      without independent investigation the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents
      submitted to us as copies.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">Based upon the foregoing, and subject to the assumptions, exceptions, qualifications and limitations set forth herein, we are of the opinion that, when the Shares have
      been issued and delivered in accordance with the Sales Agreement for the consideration provided for therein, such Shares will be validly issued, fully paid and non-assessable.</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">&#160;</div>
    <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">The opinion expressed above is subject to the following exceptions, qualifications, limitations and assumptions:</div>
    <div style="font-family: 'Times New Roman'; font-size: 12pt;"> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </font> </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <div style="text-align: center; font-family: 'Times New Roman'; font-size: 8pt;">Abu Dhabi <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Beijing <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font>
            Brussels <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Century City <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Dallas <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font>
            Denver <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Dubai <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Frankfurt <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font>
            Hong Kong <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Houston <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> London <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font>
            Los Angeles<font style="font-size: 8pt; font-family: 'Times New Roman';"><br>
            </font>Munich <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> New York <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Orange County <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Palo Alto <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Paris <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> San Francisco <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Singapore <font style="font-size: 8pt; font-family: 'Wingdings 2', serif;">&#8211;</font> Washington, D.C.</div>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);"></div>
    </div>
    <div><img src="image01.jpg">
      <div><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Coeur Mining, Inc.</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">February 23, 2023</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Page 2</div>
      </div>
    </div>
    <div>
      <div> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <table cellspacing="0" cellpadding="0" id="z145f9837d93a453190839f26a172e00a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">A.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">The effectiveness of the Registration Statement under the Securities Act will not have been terminated or rescinded.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3e59ece7e3464b9e9d4f500db1af322a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">B.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">We render no opinion herein as to matters involving the laws of any jurisdiction other than the Delaware General Corporation Law (the &#8220;<u>DGCL</u>&#8221;). This
                opinion is limited to the effect of the current state of the DGCL and the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such laws or the interpretations thereof
                or such facts.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zcd6365b7b3de4223a99a5f82d55abfed" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 36pt;"><font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
              </font> </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">C.</td>
            <td style="width: auto; vertical-align: top;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">All offers and sales of the Shares will (i) comply with the minimum offering price limitation and (ii) be completed on or prior to the &#8220;ATM Offering Deadline,&#8221;
                each as set forth in the authorization of the offering and sale of the Shares by the Company&#8217;s Board of Directors.</div>
            </td>
          </tr>

      </table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;">We consent to the filing of this opinion as an exhibit to the Registration Statement, and we further consent to the use of our name under the caption &#8220;Legal Matters&#8221;
        in the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules
        and regulations of the Commission promulgated thereunder.</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">Very truly yours,</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">/s/ Gibson, Dunn &amp; Crutcher LLP</div>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
      <div> <font style="font-family: 'Times New Roman'; font-size: 10pt;"><br>
        </font> </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
  <font style="font-family: 'Times New Roman'; font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cde-20230223.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<xs:schema targetNamespace="http://coeur.com/20230223" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cde="http://coeur.com/20230223" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cde-20230223_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cde-20230223_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://coeur.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cde-20230223_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cde-20230223_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.1.2.5118 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://coeur.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cde-20230223.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://coeur.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  5 ,$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WOQ;XANH-
M6L="T78-2O#EI7&X0)ZX[G@G\*T$\-QF'$^I:K+/CF;[6RG/J ,*/IBN0U,_
M8/C+9W%UQ#<QA8V/3)0K_/\ G7?:Q=7-E9/<6EJESY8+.C2^6< 9XX.37747
M(H*'57.6F^=S<^CL9^C:??IH]U9:I>74LBS.(KD2;9&CX*G(_+\*Y_X6SWFJ
MZ?>W.HZA>7$JRF!0TIPHP.<>O/6M[PCX@D\2:;)>BS%M;[BB9EWLQ'7C Q7/
M_!G_ ) >H?\ 7VW_ *"*=FH5.9:W1*:<X<KTLROX>2\O_&>N:9<ZOJ9MK0?N
MMMP0PY'4]^M:'@75M1E\0:UHU]<F]BL6Q'<,H#?>Q@D?YX-9.@V"ZA\1O$\;
MSW,('.;>4QD\CJ14_AN:?PSXX;PV'6XL+A3-&[(!(I(+?,P^]T(YK>I%24HK
M?E3_ ,V94Y.+C)[7:_X!=T>\/B/Q-K=M?7MQ"MG)Y5O:0S&+*C(+G;@L<_E6
MQ#++X9T34I]5NI;NWMY&D@>1]TA0@80GUW9%9/B;PC;Z\RZUH5V;;4&4.DL;
M827T.1R#[C\:P+C4]0\0_#/4TNP6O+"95E8#EU4@DGW'?Z5"A&K;E>FB:[%\
M\J=^9:ZM/N=-X8M[WQ%IZZKK%Y<QI<$M!:VTK1)&F<#)7!8GW-9^KZE?>"]=
MLQ/=SWNAWAVD7#;Y(&[X;J1SGGWK?^'ES'=>#=,:,@[(O*8#LRG!KG?C/B72
M=,MD&ZXFN<1J.I^4C^9%33]ZNZ<EIJK#G[M!5(O71EKXBKJENUC<Z#?7BW,\
MI7R$DRC@(6X'_ >G>MOPAXA@\2Z3YJ?N[E!LN(@<%&]1['L:@UB-H;SPI$YR
MZ7.TGU(A<5@^,='NO#VJ?\)/X>7&#F\MQ]UU[MCT/?TZ^M**C4A&F]'T?SV8
MY.5.;J+;JOU-KPW;W">)-:2>_O9X;62-(8Y9BR@,@8Y]>O>NENX?M%M)%YDL
M6X8WQ-M8?0URW@75(-9U#6[^UW"*:2$X8<J1$ 1^!KKCT-85DXSL]]/R-J-G
M"Z\_S/./AVEYKUE?RZCJ^J,\,YB39<%0!C^=7-8U;4_!NI6C7UT^HZ)<ML+R
MJ/-@/U&-PQSSZ&H?@W_R#-6_Z_#_ "%+\9I%;0[*S0;[F>Y'EH.2< C^9 _&
MNQI2Q+IM:/\ R.5-QPZJ)ZDGQ4N[JPTRSOM,O[FW>241'RI,(RD$YQTS[UV5
ME;>5IZ0F6>3*<R22%G.>^:X'XHV\EMX'TB.7EH)8D<^X0BO1+1UDM870@JR*
M0?48KGJI*C&W=F]/6K*_9'*^'K&>?4->AN=3U&2."X\B'-P044HK?GSU-<WX
M?\2W^AZ]+;Z]<SW&E7$\D,%U,<[&1BO)]/7\#79^&#OU+Q#(O*-?;0?=8T!_
M6LS2]'M=>\-ZC97BY1K^Y*N.J-YAPPK13BN936FGRT,W"3Y7!ZZESQXLZZ!)
M>6-[<VT\13:T,F P9P#D=#P:I>.K.]L]!BDTG4=0CNUDC@7]^3YNYL?-GOD]
M:Y*75;[1M-O/"NN[F=3']CGZAU\Q2!],#CTZ5Z#XW/\ Q*K;_K^MO_1JT<CI
M2@GJK_>M YU44FM-/N>I4\!^)?[9M'L[X>5JUI\D\;#!;'&['\_>DM;6=/'4
M\!U"^>T2U6Y6%IB5#ER#GU''2J/COP[<"Y3Q#X?S'JMM\TBH/]<H]NYQV[BC
MP7KT7B+Q%+>QH8Y!I\<<T?\ =<2-G'J.:3@G%U:>S6J[/^MAJ34E3GO^:_K<
M[FBEHKB.PR?$6@6.OVJP7Z-E#NCE0[7C/J#5 Z1K LVL3KHEB=#'YDMH&D"D
M8^\& )]\445I&I)+EZ&<J<6[]270?#AT+07TW3[Z0%F+B:2-6*YQG XJ'PIX
M7D\-Q3PVVHO-#,2Y62(</C&<@_I110ZTW>[WW!4H)JRV*MEX.NK+6;K5+;6Y
M5N[G/FDVZE6S[?A6CI'AF"QU:;5+FXFO=3E&TSRX&T>BJ.!113E7G+=B5&$=
MD5K+P_?Z5');:7K#16<CLT<<UN)##DY(5LCCV(-:>@Z'::+IK6=N&D5V+RO+
MRTK-U+444I5926K'&G&+T,NT\,/HMQ-+H&H-9V\S;GM9(A+$#ZKR"/SJU:>'
M5.K)JFJW+W]]&-L)9 D<(_V4'?W))HHINK-ZMB5**=K"Z[H=QJE_9W,>I/;"
MS?S8D6$-\^""23UX/2MM4)B"RD.=N&.,!O7BBBH<VTD^A:BDVUU,;PWX?MM!
MGU'[$Q$%U*)5BQQ%Q@@'TK6O(YI;=TMIA!*PP)"F_;^%%%$IRE+F>X1BHQY4
M<IH/@Z[T'SQINMR*DS;G62V5P6]1SQ6G9>&K>/5%U._GFU#4%&$EGQMB'^PH
MX%%%7*O.3;;W(C1A%));%_6M+M=9TV:QOD+0R=<'!4]B#ZBL33O#^K:?;+8V
M_B&3[(@VIOM5:1%] V?Z444HU)17*MARIQ;YNIMV.FIIVE_8]/<Q$ D2N-[%
MSR7;U)/-4O#>B3:(L\;:@]U%+(TQ5X@I#L<D@CM[445//*S7<?)&Z?83Q5X=
MM?$%K$)CY5Q XDBF49*X()'N#3O$VB2ZY##"M^]K%'(LI"1ABS*<J<GT/:BB
MJ522M9["=.+O=;FM:I+' B3RB64#YG"[=WX=JQ]+\.VNF>(;[4K,^6+R,!X0
:ORA@<EA]?2BBI4VKI=1N*=F^ANT445)9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image02.jpg
<TEXT>
begin 644 image02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !& (D# 2(  A$! Q$!_\0
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MW(69HV$9/9L<?K7END175MY<6GZ%/%/]B@%W/);R!FG$\0=9-WRRD@NP<9(
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ML@*R1K*%8X90PRN1VR*Y+1O \MIK,&H7U['=2Q2I)DQ'+,L<J!^6(5OWO10
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MENC8PF>5E=W(ZD,K X]=RJ?^ C/2DNM!TZY7YK948OYA>,E3DNLAZ=<LJDT
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139951644901264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coeur Mining, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000215466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-0109423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 S. Wacker Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">489-5800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (par value $.01 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CDE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>brhc10048619_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cde-20230223.xsd" xlink:type="simple"/>
    <context id="c20230223to20230223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000215466</identifier>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230223to20230223"
      id="Fact_487868727f434ef59ce67b8e0fc20c91">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230223to20230223"
      id="Fact_b78026c98294479babbbf526fa4fb3f3">0000215466</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20230223to20230223"
      id="Fact_469625cad05f4f449d7a4a613cb6f0b4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230223to20230223"
      id="Fact_09c6b6c393fd4630803b3ab8d2ed30cf">2023-02-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230223to20230223"
      id="Fact_fe17b5a287aa4d15a203553ca67aef5b">Coeur Mining, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230223to20230223"
      id="Fact_6e080d9efc2f451eb9a16d4a9a19c719">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230223to20230223"
      id="Fact_01eeabce43754e6faffd908ca0f2e086">1-8641</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230223to20230223"
      id="Fact_ea2579092e004ad5b7923e8622a1ada0">82-0109423</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230223to20230223"
      id="Fact_9d69921b73b04a06ade81db606ff8d84">200 S. Wacker Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20230223to20230223"
      id="Fact_a9b84552928648cfbc48785c2cf7a927">Suite 2100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20230223to20230223"
      id="Fact_96fcb7e5c9634fafa1d9ef1f5e66b1d1">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230223to20230223"
      id="Fact_468760e1e5124395bfa2592e2ff571c6">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230223to20230223"
      id="Fact_2e07e99441d3457e854116a958f462be">60606</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230223to20230223"
      id="Fact_8cab33a2567f40b2bdfec9c6c3eb458d">312</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230223to20230223"
      id="Fact_0f5e0f60cc05474db2431ee854b6dc9b">489-5800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230223to20230223"
      id="Fact_5d039c480f6d42159a2463ca3e4a8600">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230223to20230223"
      id="Fact_2640b58eedb34fe6bab45164cce13bd0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230223to20230223"
      id="Fact_9e02159e0ee341c188b03a57680cd9a1">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230223to20230223"
      id="Fact_2620bb9c7fa340a589e814833c78f9ce">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230223to20230223"
      id="Fact_bf8c08b66cdc442ca20ee532962b450c">Common Stock (par value $.01 per share)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230223to20230223"
      id="Fact_39ca8723c7b94777bf9d7621b11e41ce">CDE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230223to20230223"
      id="Fact_7ab7ac66a41548e487d4a3ac3d3e9157">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230223to20230223"
      id="Fact_a2f1f6cc2fa24147bbda075d3f44d7cb">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 7#A75F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
M8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#
ML9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/
MN]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DW
MY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !;
M.%=6!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P
M+GAM;%!+ 0(4 Q0    ( %LX5U8@-SJ-[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %LX5U:97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 6SA75K:9D8):!   +!$  !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %LX5U:?H!OPL0(
M .(,   -              "  9T,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10048619_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://coeur.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10048619_8k.htm">brhc10048619_8k.htm</File>
    <File>brhc10048619_ex1-1.htm</File>
    <File>brhc10048619_ex5-1.htm</File>
    <File>cde-20230223.xsd</File>
    <File>cde-20230223_lab.xml</File>
    <File>cde-20230223_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10048619_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10048619_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cde-20230223_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cde-20230223_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cde-20230223.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cde",
   "nsuri": "http://coeur.com/20230223",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10048619_8k.htm",
      "contextRef": "c20230223to20230223",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://coeur.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10048619_8k.htm",
      "contextRef": "c20230223to20230223",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-23-008161-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-008161-xbrl.zip
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MG936M8#+P$[0@$7$C&S'8&& #9?:&'X"XAG!W8R&S'++;$#.1B+](7&2UN*
MQ?@*B^7LT#5.7%02B\]RNNGPV6]_\ YYS* L9*)NW@W&<$B8;7F.S=P(1Q$-
M=)]@/3)A$-T-]+6A^:YM/,\PO LIZN/)49DF(TJ2ED:%8=/Q CV (=!M3)W0
M"TR+^:YI8@-3K&\2\IF:;NB!O<*+NO_(*)W7NJ;TWKHB!..M5!E*!4KS 1/H
M/V/!,\J)'!MIS7E=[6V_,U4"W>^DPR'/,ME;J210P8\/[NAK'.FC9J]YT43=
MX2A.IS#4BX*(3M/F9MU>(0G5E<RI*#=G93;TT>//G]6CLH,US'4/MG@\;KR;
M)=BG5+ L*W^.><*,FA4(J!L$IA%Z5@A60'<Q9;Y!0U=WH\BG_B:)/U/7$;#[
M'YA\!V8_$$NAU,[ZS, Z%,T:BC@(?=MQS, $'\ G44CD;*!#3!)Y.#"]#5"\
M&'/0O2:PU7UQZ\#EF>BG5TF=>&Y$0H\Y)' M&]P:;$A_U(@<YKJA03>8E=SK
M#("U+M/[HJ6,RIDX!Y^5J[4JM8RN[[DZ,YACF+85.&$$]AZ,O1E%CF>039RN
MH^-UR9%[:FOST:1)2H<,_CXWC,;>K[\8KO[I#GBL%.MB.NQ1O+-5:?U-Y?0\
MA2@D_E\^NA;N@)OFL2"P;8-:MN,QW[$-P\6!XT>V:X9L@_$$H=:7IY17>&I/
MX9.]-E4*=KJDN/2^1@+$AX]PC-B$D7'.?\@4"YALECW417G53/^R P!<CB2;
MOS5WZ"62?_-LZ*^_^*;A?<I R\1L-$@3AA+E3._(("(>2W\,8<$P($)9NV 4
MM+56_4C3M@_@UQ0.Q.>A98'1<+W(UD,SI!$C 7&)Q4+;\>D&"L<RS.OJ9GN]
M83M.@3'/97^6,PA@4O7(U0G1'=NS:0@FS6!2!X8N)<$F&5_;#S3'7W8 7L,\
MSNJ56'=OO3-@Y#N"\!+AT4BDH-1DR!FF$Q2R.+U"/%*%AZD8(E_['?$,."9G
M"57KYE#&A^,XQPE+QUD\11F$*UDT5:]$/)9<E8: ,*Y"5EE02T*/H1Z!<#*M
MRB)PU],K>&\NL#*YQF40F+5?(B_]8O._FP50),995JRM.P:J]N5+CQ1+/5/
M5"RA6&EE'L[>:S7''X+GP,8RQ3!.RC [JZD/A^I6 %$#J!!JFX838--V+8(M
M9F/?U3=(=2VEBL,TC4,,_)V#>$EK/#%=0]KC>WA7Z\E9K/=82<[E 7U<,[[:
M9)>4!GK528U&8Y&-I0X +=(; Z?;IE/J ZD(+L"E@A<Y(+1/<K1E>*ASV$-
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MK/NMATZ.3H].OT)8?OI\H?4[&[$U[;]W0KWB1&IC[PLTULI:J#^ 9C)U*MZ
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M5T3>T;D]>O3]3@YN^<4=7%=GP49,QY"NU-^_J[:A;44NDVBQO,!S0XDCR0S
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M;Z_NUA@-HMW9G>-04RI9=R?G,IG6P9]/R.WI"&Y@1#C!?O$*T?.>9X/("%O
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MCK =^B(6(CB'K6@Z+>A\4A,C.C(QR-#0K9>>7V&%MP(K?/(55O@55KAS@O?
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M!LZ4NG%BI<0-F2P7%,)A/G?A]M AI(8_LJFY!;(M(-"4]&&D@HYUN?X4C(
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M$]@W!5.!? 0C(\6:?05[@0&*IP.?.WXCI_Z=LAWT(>=$#=M.V<Z')4;5Y@\
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M(L(V09%I%498+B7O$&TTEPJ_9(CJ3$G)=UMK^=06QF72;8E\$AUI9J?,:(B
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MW;+&U5%^G "3.,V<^QMP&S3JJ$'QDQK4WWE6+;:X;4K&-QK05 _%O9HDSX+
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MT[8/I=P4%,)EUN8'OS3-1P&*2S5@>(Z(4)6NK>1:4SF8[,51ZHJJ//[N1#<
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M]T72"$'1$KI>VNRR@T8VN8LV]U%U_O@WHG8BH^ F-6[4@WKRT/%$1(O\$AO
MF,::RJTXMF4F6/#ED5K"U238&9C$:+Q.>EOLUB39Z(U8+R*%^WMNI]/""Q3!
M5E!U$3/)IDK/KQ%/6B_8M!.1OU(N_IH.B<,6W5G$G;Z0&I62>&>4)'^M,7YG
M=U$470Q,O&1OHK"/MQE:D>?E:D6[$4M*=/M@1\RR:/?9R/2+0ZY3C!_?.V8/
M;,-B)=6%9KMT 9C<U!N&Q2'<+!OM]2$2OKM!<Y(PWX:,"60D2 K(OUB\#RT]
MP<O+?7IK+4L/P+D$4?;!G32R5Z_?O#^QS6D=W8^;/$4+W0AJU_;G>B=:-HE)
MQ8-#"B3UPE0TI_3X887C^^>CI^FC1X_H+60;K@_K3+"TQ")0+@/5]:-13J=
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MJK)]U._S8*]2QA,Y.[=:0KPMB0(]3U'UDQ[$A/T8?XW0"[;R7@YZ[G IZ+G
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M90""43U5,9DU)9@U(0#G@X=HP.__?[X@$BZX9P7=RIJ7JW$1WT50@D!@2SG
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M$_8SH,ED"S@)*\Q2W/.I^+7.@'3\N,*BD,U4DD1D4]CMM&4?6D03<MH"B2E
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MX]GW.W%0S-\\[5QNA-C'445V\P=02P,$%     @ 7#A75I""%#9^"   =%@
M !0   !C9&4M,C R,S R,C-?;&%B+GAM;,V<76_;-A2&[P?L/W#>S0;4=BUC
MPQ(T+K(L*8*E29"DV!>&0I9I1Y@L!I3<./]^I"3:(GE(*14EZZ9U>-[S\NLY
MDJQ$>O=^NX[0%TR3D,0G@\GH[0#A.""+,%Z=##;)T$^",!R\GWW[S;OOAL,/
M.,;43_$"S5_0KY3X"QHN5AC=WMTLPP@C;SJ:C+S13Y/)+Z7P<,C3HS#^[YC_
M,_<3C%BW<7*\3<*3P6.:/AV/Q\_/SZ/GZ8C0U=A[^W8R_O/CU7WPB-?^,(R3
MU(\#/$!,?YQDC5<D\--LS*7T[9Q&PF ZWO5E5/"?AD(VY$W#B3><3D;;9#$H
MALC#-3H1\JVF+^8T.3HZ&F?1G909A1;KW;39ZB&4KQ\E$;[#2\3__W1W:<P^
M&G/%.,;IE3_'$>LR2T]?GO#)( G73Q$6;8\4+V&?B-*=#5^=([XZDY_YZGR_
M=QXW&=Z*P_1 4C]R,\[,3Q^KUDWS05^[6EK;D*]=KC(K<MS!*I>Z:3[H6TQ#
MLCB/%^T/7.W*U>#O4Y]V@(K>6?,)M#]J8*@1;[IBGZ1^\3;%\0(O1,_<VW+L
MS+K.#K:9\\Z;!))KQ,\BA.K329AKYIC@8+0B7\8+'#)GS^,?AOQ#-@OVP^<S
MPDZ?I_,DI7Z0"J=L$B<#,):&*1^[$AO+ ^7YTE I3LB&!ECI01O!YV@>O6J1
MI#W.AV8R74>L6WYA@./AI_L!"A<F[2QK0O^(QG_?C?>CUF=Z2N5]\6D@AL0^
M5DRC4(P#PDZ63^E0FM&2DK5I'TC%\A6KD?D=(TF&4H(,N>/6B?N-!)LUCM,'
MYJC@ (6*:<BA!KB5C5S1!GB:8-.D,]&">--A00/7G]C73<:LK!*4Z9GM0_8'
M#5-VR#TCZ_4F#O.+[42AP:HIIF70-. /='0%HLW<1*0Y9U:$D!P[+*/V72,U
M%UFF%I0+?"U>[7-\3Z(P"%/V??8CN^"@H1\I2)D%Q10A00-\=3M7[!J=3> :
M$F;[=B0"AT76LD>DSJK*L.I:0:K)I7U,;RGF]8'9$F1'>GZQ2V^62TP5A*J%
MQ61MP@;XFFU=85S9@PGGBL09BP^#D@#E"I1)#@MXC5TEKUE_&7ASC@"_RK7S
M KA,D@VFM<O *(>+ 9"[*PG-O*7",/53LSS@=+U(<EU_:\6\]7#%6+?'6C=:
MIJ%Z##VT7T.GK/<%'\%%Y*\44,%8,5TEUJ 4)"=7W$.F)LAU[6S7A'C;8=F%
M=X%4+)Y,I203" *YW=V(N B3P(_^PCZ]8"WJM\0*E7)[0E,YN%.A>+J^:0';
M5]V_@++VMS+R*.)AE,7[<5_#M(>D]H+#=SN4!/7&!^C7-=_Y'?9JP@$=R+BD
M<T9YR;4=SO4.ZI&NYFFLYX+^T0[M)\B[8>EMQ)=28.8US^ZHW_U"[#?V7=A
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MB5 /'HBQ;ABIM\#PF;VL5L_NNE/Q#L?26ERQ3_S-OT53F+\I=_8_4$L#!!0
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MU=,?A7-BY#I9,/"D;U),C>B6%$INR!VO&8U)2'+NU6\HQXP@_6.9':!V> ,
MGLJU9=3M[H;Q2E_(?:XIP\*6. UQ\0L*\5,==KM<5NZ3ZX%RH5Q >+HW+JM&
M?U<>Y0/(?2Z-_SC+MI@U=H,5;O:$ 0[>&74EGN</0S;EDN?VTJ[\RA).^ 'Q
M>_-#1/P1O\_^^#]02P$"% ,4    " !<.%=6':(Z< ,2   M>   $P
M        @ $     8G)H8S$P,#0X-C$Y7SAK+FAT;5!+ 0(4 Q0    ( %PX
M5U8P/.3'%+   &]7!  6              "  302  !B<FAC,3 P-#@V,3E?
M97@Q+3$N:'1M4$L! A0#%     @ 7#A75FA.8#DP#   =CX  !8
M     ( !?,(  &)R:&,Q,# T.#8Q.5]E>#4M,2YH=&U02P$"% ,4    " !<
M.%=6.DA*7T(#   M#P  $               @ '@S@  8V1E+3(P,C,P,C(S
M+GAS9%!+ 0(4 Q0    ( %PX5U:0@A0V?@@  '18   4              "
M 5#2  !C9&4M,C R,S R,C-?;&%B+GAM;%!+ 0(4 Q0    ( %PX5U;)%+"3
MV04  .H^   4              "  0#;  !C9&4M,C R,S R,C-?<')E+GAM
7;%!+!08     !@ & (L!   +X0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
